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About this guidance
Who would find this guidance useful?
This guidance is useful for agencies, organizations, and institutions that compile and use health technology 
assessment (HTA) reports. 
Purpose and scope of this guidance
The purpose of this guidance is to provide methods for an integrated assessment of complex health technolo-
gies. It describes a systematic process (the INTEGRATE-HTA Model) for assessing complex technologies that invol-
ves stakeholders, considers effectiveness, cost-effectiveness, ethical, socio-cultural and legal aspects, patient 
characteristics, as well as context and implementation issues. The INTEGRATE-HTA Model outlines an integrated 
scoping process, a coordinated application of assessment methods for different aspects and an integrated and 
structured decision-making process. It is based on concepts and methods presented in the other methodological 
guidances developed in the INTEGRATE-HTA project (www.integrate-hta.eu).  
Added value for an integrated assessment of complex technologies
Traditional HTA assesses technologies independent of context, implementation issues, and patient characte-
ristics. It also assesses different aspects of a technology only side-by-side and not in an integrated way. The 
INTEGRATE-HTA Model presented in this guidance structures assessments of complex technologies which take 
context, implementation issues, and patient characteristics into account and might thus be more meaningful 
for real-life decision-making.
INTEGRATE-HTA
INTEGRATE-HTA is an innovative project that was co-funded  by the European Union under the Seventh Fra-
mework Programme from 2013 till 2015. Using palliative care as a case study, this project developed con-
cepts and methods that enable a patient-centred, comprehensive, and integrated assessment of complex 
health technologies.
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Challenges in assessments of health technologies 
In recent years there have been major advances in the development of health technology assessment (HTA). 
However, HTA still has certain limitations when assessing technologies which 
ﬁ are complex, i.e. consist of several interacting components, target different groups or organizational 
levels, have multiple and variable outcomes, and/or permit a certain degree of flexibility or tailoring 
(Craig et al., 2008),
ﬁ are context-dependent - current HTA usually focusses on the technology, not on the system within which 
it is used,
ﬁ perform differently depending on the way they are implemented,
ﬁ have different effects on different individuals.
Furthermore, HTA usually assesses and appraises aspects side-by-side, while decision-making needs an integra-
ted perspective on the value of a technology. In the EU-funded INTEGRATE-HTA project, we developed concepts 
and methods to deal with these challenges, which are described in six guidances. 
Because of the interactions, an integrated assessment needs to start from the beginning of the assessment. 
This guidance provides a systematic five-step-process for an integrated assessment of complex technologies (the 
INTEGRATE-HTA Model).
Purpose and scope of the guidance 
The aim of the INTEGRATE-HTA project is to provide concepts and methods that enable a patient-centred, com-
prehensive, and integrated assessment of complex health technologies. The purpose of this guidance is to struc-
ture the overall HTA-process. The INTEGRATE-HTA Model outlines an integrated scoping process, a coordinated 
application of assessment methods for different aspects and an integrated and structured decision-making 
process. It is intended for HTA agencies, HTA researchers and those engaged in the evaluation of complex health 
technologies. As it links the assessment to the decision-making process, it also addresses HTA commissioners and 
other stakeholders using or planning HTAs. 
While all technologies are arguably complex, some are more complex than others. Applying this guidance might 
lead to a more thorough and therefore more time-consuming process. Depending on the degree of complexity, 
one might choose to follow the whole process as described in this guidance, or only focus on certain steps. 
The guidance provides an operational definition to assess the complexity of technologies which can be used to 
identify specific aspects that will need more attention than others. What the guidance does not provide is a 
post-hoc solution for assessments that have already been completed. 
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Development of the guidance 
The INTEGRATE-HTA Model presented in this guidance was developed based on a systematic literature search 
on approaches for integration, on the experiences of traditional HTAs, as well as on the other methodo-
logical guidances developed in the INTEGRATE-HTA project. It was tested in a case study on palliative care 
and iteratively revised during the practical application. The guidance was again revised after internal and 
external peer-review.
Application of this guidance 
For a comprehensive integrated assessment of a complex technology, we developed a five-step process, the 
INTEGRATE-HTA model. In Step 1, the HTA objective and the technology are defined with the support from 
a panel of stakeholders. An initial logic model is developed in Step 2. The initial logic model provides a 
structured overview of the technology, the context, implementation issues, and relevant patient groups. 
It then frames the assessment of the effectiveness, as well as economic, ethical, legal, and socio-cultural 
aspects in Step 3. In Step 4, a graphical overview of the assessment results, structured by the logic model, 
is provided. Step 5 is a structured decision-making process informed by the HTA (and is thus not formally 
part of the HTA, but follows it).
ﬁ Step 1: In step 1, the technology under assessment and the objective of the HTA are defined. Especially 
for complex technologies, such as palliative care, the definition of the technology alone is a challenge 
that must not be underestimated. It is recommended to do this based on a tentative literature review and 
with  the support of stakeholder advisory panels (SAPs) which should comprise clinical experts, acade-
mics, patients, possibly their relatives and/or other caretakers, and the public. The setting of an objective 
considering all relevant aspects of complexity and structured by assessment criteria is important. The as-
sessment criteria will usually reflect values of the stakeholders as well as the input from the theoretical, 
methodological and empirical literature.
ﬁ Step 2: In step 2, an initial logic model is developed (see Guidance on the use of logic models in health 
technology assessments of complex interventions). The model provides a structured overview on partici-
pants, interventions, comparators, and outcomes. Parallel to this, groups of patients that are distingu-
ished by different preferences and treatment moderators (see Guidance for the assessment of treatment 
moderation and patients’ preferences) are identified. Specific context and implementation issues are 
also identified as part of the initial logic model (see Guidance for the Assessment of Context and Imple-
mentation in Health Technology Assessments (HTA) and Systematic Reviews of Complex Interventions). The 
product of this step is the logic model as a graphical representation of all aspects and their interactions 
that are relevant for the assessment of the complex technology.
ﬁ Step 3: In step 3, the logic model serves as a conceptual framework that guides the evidence assessment. 
Depending on the specific aspect (e.g. effectiveness, economic, ethical, socio-cultural, or legal aspects) 
different methods are available for the assessment (see Guidance for assessing effectiveness, economic 
aspects, ethical aspects, socio-cultural aspects and legal aspects in complex technologies). The outputs of 
step 3 are evidence reports and standardized evidence summaries for each assessment aspect (e.g. report 
on economics, report on ethical aspects, etc.). 
ﬁ Step 4: In step 4, the assessment results of step 3 are structured using the logic model developed in step 
2. Whereas the initial logic model in step 2 specifies what evidence is relevant, the extended logic mo-
del to assist decision-making in step 4 visualizes the assessment results as well as the interaction with 
respect to the HTA objectives. It also allows for the consideration of different scenarios depending on the 
variation in context, implementation and patient characteristics.
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ﬁ Step 5: Step 5 involves a structured decision-making process and is not an integral part of the HTA in 
the narrow sense. Decision-making can be supported by applying quantitative e.g. MCDA- (Multi-criteria 
decision analysis) or qualitative decision support tools. Flexibility in the application of these tools by the 
decision committee is crucial, taking different decision settings and evidence needs into consideration.
Conclusions 
In current HTA, different aspects are usually assessed and presented independent of each other. Context, imple-
mentation issues and patient characteristics are rarely considered. The INTEGRATE-HTA Model enables a coordi-
nated assessment of all these aspects and addresses their interdependencies. The perspective of stakeholders 
such as patients and professionals with their values and preferences is integrated in the INTEGRATE-HTA Model 
to obtain HTA results that are meaningful for all relevant stakeholders. Finally, health policy makers obtain an 
integrated perspective of the assessment results to achieve fair and legitimate conclusions at the end of the 
HTA process. The application of the model will usually require more time and resources than traditional HTA. 
An initial assessment of the degree and the character of complexity of a technology might be helpful to decide 
whether or not the whole process or only specific elements will be applied.
Guidance on the integrated assessment  





AHP Analytic Hierarchy Process
ANP Analytic Network Process
BN Bayesian Network
BWS Best-Worst Rating
CADTH Canadian Agency for Drugs and Technologies in Health
CICI  Context and Implementation for Complex Interventions
COPE Creativity, Optimism, Planning, and Expert Information
CRP Consensus Reaching Process
DCE Discrete Choice Experiment
DST Dempster–Shafer Theory
ELECTRE ELimination and Choice Expressing REality
EUnetHTA  European network for Health Technology Assessment
EVPI Expected Value of Perfect Information
EVPPI Expected Value of Partial Perfect Information
EVIDEM EVIdence based DEcision Making
G-BA Gemeinsamer Bundesausschuss
GRADE Grading of Recommendations Assessment, Development and Evaluation
INTEGRATE-HTA Integrated Health Technologies Assessment for the Evaluation  
 of Complex Technologies
INAHTA The International Network of Agencies for Health Technology Assessment
IQWiG Institute for Quality and Efficiency in Health Care
HTA Health Technology Assessment
MACBETH Measuring Attractiveness by a Category Based Evaluation Technique
MAUT Multi-Attribute Utility Theory
MCDA Multi-criteria Decision Analysis
MRC Medical Research Council
NGT Nominal group technique
NICE National Institute for Health and Care Excellence
NIS Negative Ideal Solution
PBMA Programme Budgeting and Marginal Analysis
PIS Positive Ideal Solution
PROMETHEE Preference Ranking Organisation Method for Enrichment Evaluation
REMBRANDT Ratio Estimation in Magnitudes or deci-Bells to Rate Alternatives  
 which are Non-DominaTed
SAP Stakeholder Advisory Panel
SEU Subjective Expected Utility
SMARTS Simple Multi-Attribute Rating Technique Using Swings
TOPSIS Technique for Order Preference by Similarity to Ideal Solution
VOI Value of Information
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development and evaluation of complex interven-
tions (Craig et al., 2008; Moore et al., 2015). 
The Canadian Agency for Drugs and Technologies in 
Health (CADTH), which provides guidelines on health 
economic evaluations, taking various aspects such as 
preferences for outcomes, equity, generalizability, un-
certainty and variability into account (CADTH, 2006). 
However, all these guidances only provide an account 
of methods that can be used concurrently, for each of 
the assessment aspects; they do not address how to 
integrate the different assessment results.
The “Guidance for the methods of technology apprai-
sal 2013” from the National Institute for Health and 
Care Excellence (NICE) divides the HTA process into sco-
ping, assessment and appraisal. The fiinal appraisal 
takes the uncertainty of the HTA results, the trans-
ferability of the results to the decision context, and 
implementation issues into account when interpre-
ting the evidence (NICE, 2013). In addition to the NICE 
approach, we provide an integrated HTA process (the 
INTEGRATE-HTA Model; for details see chapter 3) that 
structures the assessment of different aspects. We also 
consider aspects that are specifically relevant for the 
assessement of complex technologies such as context 
and implementation issues. 
The instrument GRADE (Grading of Recommenda-
tions Assessment, Development and Evaluation) aims 
to assess the quality of evidence, the balance of 
desirable and undesirable consequences, values and 
preferences, and the use of resources. The INTEGRA-
TE-HTA Model acknowledges the parts of the GRADE 
assessment that are formal and rigorous (such as on 
quality of evidence). Our approach adds a systematic 
process for the parts of GRADE that are not formali-
zed (such as assessment of values and preferences). 
As GRADE does not inform users about how to take 
qualitative evidence such as context and implemen-
tation issues into account, it was developed further 
resulting in the instrument DECIDE (Developing and 
Evaluating Communication Strategies to Support In-
formed Decisions and Practice Based on Evidence) 
(Guldbrandsson et al., 2015). DECIDE extends the list 
of criteria that are provided by GRADE and provides 
computer-based tools to comprehensively illustrate 
different criteria and the underlying evidence. All 
the same, these criteria are presented alongside one 
another rather than in an integrated manner. The 
INTEGRATE-HTA Model provides a process and tools to 
integrate all assessment criteria.
1 PURPOSE AND SCOPE  
OF THE GUIDANCE 
1.1 AIM OF THIS GUIDANCE
The aim of the INTEGRATE-HTA project is to provide 
concepts and methods that enable a patient-cente-
red, comprehensive, and integrated assessment of 
complex health technologies. The Oxford English dic-
tionary defines integration as “…the making up or 
composition of a whole by adding together or com-
bining the separate parts or elements; combination 
into an integral whole” (Stevenson, 2005). Following 
the definition of the Oxford dictionary, this guidance 
focuses on how to achieve an integrated assessment 
process of aspects relevant for complex technologies 
from the outset of the assessment to the final decision 
(the INTEGRATE-HTA Model). 
1.2 TARGET AUDIENCE FOR THIS 
GUIDANCE
This guidance is intended for HTA agencies, HTA rese-
archers and those engaged in the evaluation of mul-
tiple aspects of complex health technologies. It is also 
useful for HTA commissioners and other stakeholders 
using or planning to do HTAs. This guidance supports 
health policy makers in making deliberative decisions 
by facilitating a transparent and comprehensive HTA 
process. 
1.3 THE ADDED VALUE OF THIS 
GUIDANCE IN RELATION TO 
EXISTING GUIDANCE
The focus of this guidance is on the integration 
of aspects relevant for the assessment of complex 
technologies. Three guidances were useful as star-
ting points for this guidance: 
The Core Model of the ‘European network for he-
alth technology assessment’ (EUNetHTA) (Lampe et 
al., 2009), which provides a comprehensive frame-
work for various aspects of health technology as-
sessments; 
The British Medical Research Council (MRC) de-
veloped a framework that specifically focuses on the 
| 14 
The methodological approach of Multi-criteria Decisi-
on Analysis (MCDA) is a well-known tool to address the 
challenges of integrating dimensions of information. 
Belton described MCDA as “an umbrella term to de-
scribe a collection of formal approaches which seek 
to take explicit account of multiple criteria in helping 
individuals or groups explore decisions that matter” 
(Belton & Stewart, 2002). MCDA has been used as a ba-
sis for developing evaluation tools such as the EVIDEM 
(EVIdence based DEcision Making) framework, which 
specifically adapted MCDA for HTA decision-making. 
Accordingly, this guidance also builds on the work of 
the EVIDEM framework. The framework consists of 15 
quantifiable core criteria that are specific for HTA de-
cision-making, such as severity of disease. The 15 core 
criteria are weighted independently from the asses-
sed technology. The performance of the technology is 
then scored against each core criterion and a value 
estimate is calculated by combining weights and sco-
res. Finally, qualitative considerations can be taken 
into account for final decision-making (Goetghebeur 
et al., 2008). The EVIDEM framework was widely tes-
ted in different decision settings for HTA (Goetghebeur 
et al., 2012; Goetghebeur et al., 2010; Miot et al., 
2012; Tony et al., 2011; Wahlster et al., 2015b). EVI-
DEM, however, does not cover all relevant aspects for 
the assessment of complex technologies, e.g. patient 
characteristics, context and implementation issues. 
Even though many criteria such as “System capacity” 
and “Unmet needs” are interrelated, the assessments 
of different criteria are not linked to each other. The 
INTEGRATE-HTA Model addresses these interdependen-
cies from the very beginning and considers the work 
of EVIDEM in step 5 of the INTEGRATE-HTA Model.
1.4 LOCATING THE GUIDANCE IN 
THE INTEGRATE-HTA PROJECT 
This guidance builds on all other methodological gui-
dances developed in the INTEGRATE-HTA project:
 ﬁ Guidance on the use of logic models in health tech-
nology assessments of complex interventions,
 ﬁ Guidance for the Assessment of Context and Imple-
mentation in Health Technology Assessments (HTA) 
and Systematic Reviews of Complex Interventions: 
The Context and Implementation of Complex Inter-
ventions (CICI) Framework,
 ﬁ Guidance for the assessment of treatment modera-
tion and patients’ preferences,
 ﬁ Guidance for assessing effectiveness, economic as-
pects, ethical aspects, socio-cultural aspects and 
legal aspects in complex technologies,
 ﬁ Guidance on choosing qualitative evidence synthesis 
methods for use in health technology assessments 
of complex interventions.
The guidance presented here structures the applica- 
tion of the other methodological guidances into a five- 
step systematic assessment process (the INTEGRATE- 
HTA Model). 
The “Guidance on the use of logic models in health 
technology assessments of complex interventions” 
(Rohwer et al., 2016) is applied to develop the sco-
pe of the HTA. Logic models provide an overview of 
the current knowledge about complex technologies. 
A logic model is “… a graphic description of a system 
… designed to identify important elements and rela-
tionships within that system” (Anderson et al., 2011; 
Kellog, 2004). Based on the HTA objective (see chapter 
3.1), an initial logic model that provides an overview 
of the current conditions regarding the technology 
under investigation is drafted in step 2 (see chapter 
3.2). 
Relevant aspects regarding patient preferences and 
context and implementation issues are identified by 
applying the “Guidance for the assessment of treat-
ment moderation and patients’ preferences” (Van 
Hoorn et al., 2016) and the “Guidance for the As-
sessment of Context and Implementation in Health 
Technology Assessments and Systematic Reviews of 
Complex Interventions: The Context and Implementa-
tion of Complex Interventions (CICI) Framework” (Pfa-
denhauer et al., 2016), and feed into the initial logic 
model to inform the evidence collection in step 2 (see 
chapter 3.2). 
For the evidence assessment, the “Guidance for asses-
sing effectiveness, economic aspects, ethical aspects, 
socio-cultural aspects and legal aspects in complex 
technologies” (Lysdahl et al., 2016) is applied in step 
3 (see chapter 3.3 ). 
The “Guidance on choosing qualitative evidence syn-
thesis methods for use in health technology assess-
ments of complex interventions” (Booth et al., 2016) 
supports the synthesis of evidence depending upon 
the type of data being synthesised at multiple points 
of the INTEGRATE-HTA Model.
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2 BACKGROUND
2.1 HTA OF COMPLEX  
TECHNOLOGIES
The UK Medical Research Council (MRC) defines complex 
interventions as being characterised by the number of 
interacting components within the experimental and 
control interventions, the number and difficulty of be-
haviours required by those delivering or receiving the 
intervention, the number of groups or organisational 
levels targeted by the intervention, the number and 
variability of outcomes, and the degree of flexibility or 
tailoring of the intervention permitted eigentlich (Craig 
et al.,2008). Shiell  (Shiell et al., 2008) highlight that 
complexity is a characteristic of the system within which 
an intervention acts as well as being an inherent charac-
teristic of an intervention itself. They describe complex 
systems as being adaptive to their local environment, as 
behaving non-linearly and as being part of hierarchies 
of other complex systems. 
Many of the traditional methods of analysis in HTA rely 
upon specific assumptions about the structure, content 
and objectives of an intervention, its implementation, 
the system within which it is intended to act and the 
potential interplay and co-evolution of the system and 
the intervention. However, to avoid misleading conclu-
sions, HTA should take the complexity of a technology 
and/or the complexity of its environment into account. 
For example, when assessing a technology such as an 
educational program to prevent the transmission of the 
human immunodeficiency virus (HIV) the success or fai-
lure might depend on the message itself (e.g. abstention 
or condoms or both), the messenger (a young celebrity 
or a respected religious leader), the target group (se-
xually active adolescents or elderly religious persons), 
the medium transmitting the message (internet spots or 
lectures), the perceived prevalence of the disease (om-
nipresent threat or small chance), and so on. Simply to 
focus on the content of the program without considering 
these other factors is not sufficient.
Complexity is not a binary property, and exists rather 
along a spectrum. All interventions could, therefore, be 
considered complex to a certain extent. This guidance, 
however, focuses on those health technologies where the 
presence of complexity has strong implications for the 
planning, conduct and interpretation of the HTA. Table 1 
lists potentially relevant characteristics of complexity. 
Consequently, when starting an assessment of (any) he-
alth technology these factors should be carefully revie-
wed with the purpose of  
1. describing the complexity of an intervention and the 
system within which it acts,
2. understanding whether this complexity matters for 
decision making and therefore needs to be addres-
sed in an HTA,
3. understanding the implications of complexity for 
the methods of HTA analysis in assessing the ethical, 
Table 1: Synthesis of potentially relevant characteristics of complexity in HTA.
Characteristic Short explanation
1  Multiple and changing  
perspectives
The variety of perspectives is caused by the many components (social, 
material, theoretical, and procedural), actors, stakeholders, organizati-
onal levels that are involved in the intervention. These are in addition 
interconnected and interacting, and accordingly exposed to changes.
2  Indeterminate phenomena The interventions or condition cannot be strictly defined or delimited 
due to characteristics such as flexibility, tailoring, self-organization, ad-
aptivity and evolution over time.
3  Uncertain causality Factors such as synergy between components, feedback loops, modera-
tors and mediators of effect, context, symbolic value of the intervention, 
lead to uncertain causal pathways between intervention and outcome.
4  Unpredictable outcomes The outcomes of the intervention may be many, variable, new, emerging 
and unexpected.
5  Historicity, time and path 
dependence
Complex systems evolve through series of irreversible and unpredictable 
events. The time, place and context of an intervention therefore impact 
on the effect, generalizability and repeatability of an intervention.
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legal, effectiveness, economic and socio-cultural 
aspects of an intervention, and
4. exposing important factors that decision makers 
need to consider in interpreting the HTA. 
2.2  WHICH DIMENSIONS OF  
INFORMATION NEED TO BE  
INTEGRATED IN HTA?
Different dimensions of information need to be inte-
grated in HTA. These are:
1. Different assessment aspects of a health technolo-
gy, such as legal or economic aspects,
2. Modifying factors, such as patient characteristics, 
context and implementation issues
3. Uncertainty of the assessment results, such as 
validity of evidence
4. Representation of stakeholders with their values 
and preferences 
These dimensions were continuously taken into account 
during the development process of the INTEGRATE-HTA 
Model and are described in detail in this chapter.
2.2.1  Dimension 1: Different assessment 
aspects of a health technology
The assessment aspects (dimension 1) comprise effec-
tiveness, socio-cultural, economic, ethical and legal 
issues. Each aspect (i.e. effectiveness, legal issues) is 
assessed by a specific assessment method. The result is 
a separate evidence report for each assessment aspect. 
Figure 1 illustrates the different assessment aspects of 
an HTA report. The second dimension of information that 
needs to be integrated, compromises factors that can 
modify the assessment results (dimension 1).
2.2.2 Dimension 2: Modifying factors: 
context, implementation issues 
and patient characteristics
This dimension includes context, implementation is-
sues and patient characteristics. When assessing the 
different assessment aspects (dimension 1), the influ-
ence of patient characteristics, implementation issues 
and context (dimension 2) has to be considered (see 
figure 2). 
Context is defined as “a set of characteristics and cir-
cumstances that surround the implementation effort." 
Implementation is conceptualized as “a planned and 
deliberately initiated effort with the intention to put 
an intervention into practice” (see “Guidance for the 
Assessment of Context and Implementation in Health 
Technology Assessments (HTA) and Systematic Reviews of 
Complex Interventions: The Context and Implementation 
of Complex Interventions (CICI) Framework”) (Pfaden-
hauer et al., 2016).
Patient characteristics can be separated into patient 
moderators and patient preferences (see the “Guidance 
for the assessment of treatment moderation and pati-
ents’ preferences”) (Van Hoorn et al., 2016). Patients 
with a particular disease or condition may respond quite 
differently to the same treatment (patient moderator). 
Additionally, patients may not appreciate all treatment 
outcomes in the same way (patient preferences). For 
example, they may differ within their values regarding 
pain and duration of life. Relieving pain through opi-
oids can worsen symptoms such as fatigue or nausea. 
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The resulting “trade-offs” between different outcomes 
will vary between different patients according to their 
preferences
Modifying factors (dimension 2) need to be described 
and considered carefully (e.g. contextual factors that 
affect the transferability of study results from another 
health care system) as they play an important role in 
the estimation of uncertainty of the assessment result 
(dimension 3).
2.2.3 Dimension 3: Uncertainty of the as-
sessment results
Any assessment result (from dimension 1) needs to be 
reported together with its degree of uncertainty (dimen-
sion 3), e.g. the likelihood of obtaining a certain out-
come such as pain relief. Uncertainty is related to the 
internal validity (such as the choice of indicators, risk of 
bias), and also to the transferability of the evidence to 
the specific situation under assessment.
2.2.4 Dimension 4: Representation of 
stakeholders, including their 
values and preferences 
The perspectives of stakeholders (such as patients, phy-
sicians and decision makers), including their values and 
preferences, represent the fourth dimension of informa-
tion in HTA. Stakeholders should be part and parcel of 
HTA, and should be included in a structured, transparent 
and fair manner. Accordingly, the values and preferences 
of the stakeholders interact with all other dimensions. 
They influence the aspects and outcome parameters to 
assess (dimension 1), identify and interpret the influen-
ce of the modifying factors (dimension 2), and decide 
on the acceptability and interpretation of uncertainty 
regarding the assessment results (dimension 3). 
3 DEVELOPMENT OF THE 
INTEGRATE-HTA MODEL
3.1  IMPLICATIONS REGARDING THE 
DIMENSIONS OF INFORMATION 
IN HTA FOR THE DEVELOPMENT 
OF THE INTEGRATE-HTA MODEL
As comprehensive strategies for an integrated as-
sessment of all dimensions of information in HTA 
are missing, we developed a new approach, the 
INTEGRATE-HTA Model. The development of the 
INTEGRATE-HTA Model is based on the assumption 
that the aspects to be assessed (dimensions 1 such 
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as effectiveness, ethical or socio-cultural aspects) 
strongly interact with each other, with context and 
implementation issues and patient characteristics 
(dimension 2), the degree of uncertainty (dimension 
3), and stakeholder values and preferences (dimen-
sion 4). 
This has four implications: 
1. The aspects of (complex) technologies (dimension 1) 
cannot be assessed independent of context, imple-
mentation issues, and patient characteristics (dimen-
sion 2). These need to be identified and their interac-
tions need to be taken into account. 
2. Integration between the different dimensions is a 
continuous process. It is not possible to assess the 
different, interacting dimensions independently first, 
and complete the integration afterwards. 
3. The resulting number of combinations regarding the 
diversity of modifying factors (e.g. patient preferences 
for outcome a, b, c multiplied with different contex-
tual scenarios x, y, z) is virtually infinite. Therefore, 
explicit choices regarding the assessment aspects (di-
mension 1) and modifying factors (dimension 2) need 
to be made at the beginning of the assessment.
4. Stakeholders (such as patients, physicians or decisi-
on makers) have different information needs: While 
some specifically want to understand interactions 
and uncertainties of complex technologies, others 
prefer a more condensed version of results.
As the different dimensions to be integrated require dif-
ferent methods for integration, we conducted a map-
ping review of the medical and non-medical literature 
to identify methods to integrate the different dimensi-
ons of information in HTA.
3.2  MAPPING REVIEW OF METHODS 
TO INTEGRATE THE DIFFERENT 
DIMENSIONS OF INFORMATION 
IN HTA
A systematic literature search was performed to iden-
tify articles on integration methods published in me-
dical and non-medical databases between January 
2004 and April 2014. Databases and keyword terms 
are provided in the appendix (see chapter 8.1.1). 
Integration methods were defined as existing metho-
dologies for integrating different dimensions of infor-
mation. These methods were appraised for applicabi-
lity to HTA. They were included if they were deemed 
to be useful to integrate at least two of the four di-
mensions of information. Detailed inclusion criteria 
are listed in the appendix. 
The four dimensions of information in HTA were used 
as categories for data extraction (table in appendix).
30 methods for integration were included in the 
mapping review. We divided these methods into four 
groups: MCDA methods, preference elicitation me-
thods, analytic methods and consensus methods. 
MCDA methods mainly consist of four different steps. 
ﬁ Criteria are developed for the assessment of the 
technology, such as public health impact, as sepa-
rate criterion. 
ﬁ  Weights for each criterion are derived, representing 
the relative importance given by stakeholders to 
each criterion. 
ﬁ  The performance of a technology against each cri-
terion is assessed and scored. 
ﬁ  Based on the weights and the scores for the perfor-
mance, an integrated measure is calculated. MCDA 
can thus provide insights into decision-making 
processes in terms of preferences and values of de-
cision makers, and the alternatives to decide on. 
The common features of preference elicitation me-
thods are the separation of a decision into different 
decision criteria corresponding to MCDA methods. Af-
terwards, these criteria form the basis for the creation 
of hypothetical decision options with different criteria 
values. Decision makers need to decide between these 
options according to their preferences. These choices 
are translated into quantitative preference scores for 
the different decision criteria and decision options. 
Finally, the decision options can be ranked according 
to these preference scores. 
An aspect of analytic methods is the definition of a de-
cision problem. A decision problem might be whether 
a new health technology can significantly improve the 
health of a specific population. Accordingly, different 
sources of evidence that are related to the decision 
problem are identified, such as population data and 
a clinical trial about the new technology. The rela-
tionship between these different pieces of evidence 
is modelled, and quantitative calculations of these 
relationships are performed. Finally, integrated data 
are obtained as results of these calculations and used 
to support decision-making. Thus, analytic methods 
provide insights into the likelihood and the magnitu-
de of an effect of new health technologies. 
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Consensus methods describe methods for a structured 
discussion and decision-making. The objective is to 
achieve consensus among participants through applying 
these methods. General consensus methods are used for 
discussions of the final information (in this case the as-
sessment results of the HTA) that informs the decision. 
Process-based consensus methods are used for discus-
sions during the assessment process that results in the 
final information for decision-making. 
A description of each method is provided in chapter 
8.1.2 (in the appendix). As a method can consist of se-
veral integration techiques the methods were disaggre-
gated into the underlying techniques. The methods were 
disaggregated into different techniques. Techniques 
were defined as similar patterns of integration in dif-
ferent methods. Nine techniques that cover specific 
dimensions of information in HTA (chapter 1.2.1) were 
subsequently identified. A detailed description of each 
technique is provided in chapter 8.1.3 in the appendix. 
The INTEGRATE-HTA Model that is presented in the follo-
wing chapter was developed based on these methods 
and techniques.
 
4 APPLICATION OF THE 
GUIDANCE 
The INTEGRATE-HTA Model is built on a) the experiences of 
traditional HTA which mainly provides side-by-side as-
sessments of the different aspects (for details see chap-
ter 1.1.3); b) the methodological guidances developed 
in the INTEGRATE-HTA-project (for details see chapter 
1.1.4); c) the dimension of information in HTA (see chap-
ter 2.2) and d) the literature review on approaches for 
integration (for details see chapter 3). The involvement 
of stakeholder panels in each step of the assessment 
process provides the opportunity for clinical experts, 
academics, patients, as well as their families, and the 
public to contribute suggestions and give feedback to 
the HTA project team.
The INTEGRATE-HTA Model, which integrates the four di-
mensions of information in HTA, is shown in Figure 5. It 
comprises five steps: 
Step 1
Step 1: Definition of the HTA objective and 
technology: The technology and objectives 
of the HTA are defined based on the input 
of stakeholder advisory panels (SAPs), a li-
terature review and the specific scoping 
procedures of the assessment methods for 
each assessment aspect.
Step 2
Step 2: Creation of an initial logic model 
to define evidence needs: The initial logic 
model visualizes the HTA objective, inclu-
ding the definition of specific technolo-
gies, the relevant issues of interest, out-
come parameters to be assessed, patient 
preferences and moderators, as well as 
context and implementation issues.
Step 3
Evidence assessment: The evidence for 
the different assessment aspects is collec-
ted and assessed.
Step 4
Step 4: Mapping of evidence: In step 4, 
the results of step 3 are processed and 
restructured to draw a model, which is 
an extended logic model to assist decisi-
on-making. Whereas the initial logic mo-
del in step 2 specifies what evidence is re-
levant to the HTA objective, the extended 
logic model represents the results of the 
assessments and visualizes the interrela-
tionships to assist decision-making. 
Step 5
HTA conclusion: At this stage, the assess-
ment results are organized in a way sui-
table for presentation to decision-making 
bodies and other stakeholders interested 
in the results. Step 5 involves a structured 
decision-making process and is not an in-
tegral part of the HTA in a narrow sense.
The process of the INTEGRATE-HTA Model is iterative in 
nature, thereby allowing revisions where necessary. For 
instance, new data illustrated in the initial logic model 
(step 2) can necessitate modifications of the HTA objecti-
ve that was defined in step 1. The INTEGRATE-HTA Model 
was applied in a case study on palliative care [see “In-
tegrated assessment of home based palliative care with 
and without reinforced caregiver support: ‘A demons-
tration of INTEGRATE-HTA methodological guidances”] 
(Brereton et al., 2016). The model was iteratively revised 
during the practical application. For each step of the IN-
TEGRATE-HTA Model, an example from the case study on 
palliative care is provided. In the following sections, the 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.1  STEP 1: HTA OBJECTIVES AND 
TECHNOLOGY
 
The first step of any HTA process is the definition of the 
assessment theme, in most cases the health technolo-
gy to be assessed. However, the starting point might 
also be a specific health problem or the intention to 
rearrange a certain area of care. Usually the process 
is initiated by the decision-making body, (e.g. the he-
alth care authority), needing a decision on the issue. 
For an integrated assessment, we suggest that this 
decision-making body cooperates with an HTA agen-
cy to develop the 'terms of reference'. These ‘terms of 
references’ are developed according to the functional 
requirements of the decision-making body, a scoping 
literature overview of the assessment theme, scoping 
outcomes from the different assessment aspects such 
as economics and stakeholder input.
Stakeholder advisory panels (SAPs) are implemented to 
involve relevant stakeholders in the HTA process from 
the beginning (addressing dimension 4; chapter 2.2.1). 
The term ‘panel’ refers to the collective information 
provided by individuals or groups independent of their 
location, as patients and busy professionals cannot 
always attend face-to-face meetings, especially when 
stakeholders are geographically dispersed. Patients, 
their families, clinicians and academics have different 
types of expertise. Their contribution ensures that the 
results of the HTA are useful to both service users and 
providers. As a result of their experience, these lay and 
professional stakeholders contribute to the scope of the 
HTA, the selection and prioritization of specific issues, 
and the assessment criteria of the HTA research ques-
tion. 
In parallel, the scoping procedures of each assessment 
aspect (see “Guidance for assessing effectiveness, eco-
nomic aspects, ethical aspects, socio-cultural aspects 
and legal aspects in complex technologies”) (Lysdahl et 
al., 2015) can feed into the HTA objective. For instance, 
assessing the complexity of the technology of interest 
at the beginning of the ethical assessment can be part 
of the general information gathering in this initial step. 
An important aspect of this task is to elaborate on how 
the scopes of different assessment aspects are inter-
related. Continuous collaboration between the various 
assessment aspects is essential to avoid overlaps from 
the beginning of the HTA (e.g. between the socio-cul-
tural and the ethical assessment)."
In order to operationalize the objective of the HTA, de-
fining assessment criteria is useful. Separating the HTA 
into clearly defined assessment criteria provides a basis 
for integration at the end of the assessment. The as-
Figure 6: Step 1: HTA Objectives and Tehnology.
Step 1
RESULT
Definition of HTA research 
question, assessment criteria 
and preliminary definition of 
specific technologies 

































Definition of relevant issues and as-
sessment criteria regarding the assess-
ment theme (e.g. access ,
continuity)
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sessment criteria can be selected from the scoping lite-
rature review on the assessment theme, a generic set of 
criteria (such as EVIDEM (Goetghebeur et al., 2008), the 
HTA core model (Lampe et al., 2009), or the criteria of 
existing decision committees such as NICE or the Dutch 
health care authority.
The definition of the assessment criteria should be 
in line with the values of stakeholders for the spe-
cific health technology. Stakeholders and decision- 
makers should come to a consensus on the definition 
and structure of the HTA research question, including 
the assessment criteria. In doing so, the values and 
preferences of participating stakeholders (dimension 4) 
integrate the different aspects that need to be assessed 
(dimension 1) from the beginning of the HTA.
The output of step 1 of the INTEGRATE-HTA Model is the 
identification of the HTA objective, including relevant 
issues, outcomes and the technologies to be assessed 
(e.g. models of care). 
Example – HTA-Objectives and definiti-
on of the health technology  
in the INTEGRATE-HTA case study on 
palliative care  
The objective of this case study was to compare rein-
forced models of palliative home care vs. non-rein-
forced models of palliative home care. SAPs from 
several European countries contributed to the HTA 
objective by providing 23 important general issues 
in palliative care (e.g. continuity of care, caregiver 
support). The HTA objective was separated into dif-
ferent assessment criteria. These criteria were de-
fined and operationalized according to the glossary 
of the International Network of Agencies for Health 
Technology Assessment (INAHTA) and the Joanna 
Briggs Institute outlined in table 2. Step 1 resulted 
in the identification of the following HTA research 
question: 
Criterion of interest Description
ﬁ   Effectiveness
is defined as “The benefit (e.g. to health outcomes) of using a technology for a particular 
problem under general or routine conditions, for example, by a physician in a commu-
nity hospital or by a patient at home.” Clinical effectiveness is defined as “The extent to 
which a specific intervention, procedure, regimen, or service does what it is intended to 
do under ordinary circumstances, rather than controlled conditions. Or more specifically, 
the evaluation of benefit to risk of an intervention, in a standard clinical setting, using 
outcomes measuring issues of importance to patients (e.g. ability to do daily activities, 
longer life, etc.)”. 
ﬁ   Cost effectiveness
is defined as an economic evaluation consisting of comparing various options in which 
costs are measured in monetary units, then aggregated, and outcomes are expressed in 
natural (non-monetary) units. 
ﬁ   Acceptability
is defined as being agreeable to defined population groups, often those benefiting from 
the technology, target groups affected by the intervention, those implementing an inter-
vention, and society at large.
ﬁ   Meaningfulness
is defined as “the extent to which an intervention or activity is positively experienced 
by the patient. Meaningfulness relates to the personal experience, opinions, values, 
thoughts, beliefs and interpretations of patients or clients”.
ﬁ   Appropriateness
is defined as “the extent to which an intervention or activity fits with or is apt in a parti-
cular situation.” Clinical appropriateness is about how an activity or intervention relates 
to the context in which care is given. 
ﬁ   Feasibility
is defined as “the extent to which an activity is practical and practicable. Clinical feasibili-
ty is about whether or not an activity or intervention is physically, culturally or financially 
practical or possible within a given context”.
Table 2: Definitions of assessment criteria used in the HTA research question about reinforced models of home-based pal-
liative care (International Network of Agencies for Health Technology Assessment (IANHTA), 2015; The Joanna Briggs 
Institute, 2014).
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Figure 7: Step 2: Logic model to define evidence 
needs.
RESULT
Logic Model to define 
evidence needs
Step 2
Initial logic model to start 
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Review and adaptation of the 
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Refinement of A,B,C,D,E: 
A)  Definition of specific technologies 
B)  Relevant issues 
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D)  Relevant patient characteristics    
(preferences, moderators) 
E)  Context and implementation issues







for providing patient-centred home-based palliative 
care [compared to usual home-based care models of 
palliative care] in adults (defined as those aged 18 ye-
ars and above) and their families?”1 
4.2  STEP 2: DEVELOPMENT OF  
INITIAL LOGIC MODEL TO  
DEFINE EVIDENCE NEEDS
 
The HTA objective, the generic logic model template 
and the relevant issues from the SAPs identified in 
step 1 are the basis of step 2. These inputs are integ-
rated by using a qualitative modeling technique (see 
appendix, chapter 8.1.3) such as a logic model. 
A system-based logic model template (see: “Guidance 
on the use of logic models in health technology as-
sessment of complex interventions”) (Rohwer et al., 
2016) is applied and transformed into an initial lo-
gic model regarding the technology of interest. The 
template allows the identification of participants, 
interventions, comparators, outcomes, context, and 
implementation issues from a system perspective. The 
generic logic model used in the case study is illustra-
ted in Figure 8.  
Thus, the architecture and structure of the generic 
logic model is adapted for the specific technologies 
of interest in accordance with the HTA objective (such 
as to compare reinforced vs. non-reinforced models 
of home based palliative care). The initial logic model 
resulting from this task aims to illustrate the system 
within which the interaction between the patient, 
the technology of interest, context, and implemen-
1 As this case study was not initiated by a decision-making 
body, our starting point was to assess models of palliati-
ve care. The literature review on models of palliative care 
identified reinforced models of home-based palliative care 
as one technology. Reinforced models of home-based pal-
liative care were selected as they clearly address the SAP is-
sue on caregiver support. This match between the results of 
the literature review (reinforced models) and the SAP issues 
(caregiver support) identified reinforced models of palliati-
ve home care as a (or the) technology of interest.
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tation issues takes place. Different inputs will feed 
into the initial logic model, from the first draft to the 
final version at the end of step 2. 
The first draft of the initial logic model (see “Gui-
dance on the use of logic models in health techno-
logy assessments of complex interventions”) (Rohwer 
et al., 2016) is adapted based on scoping literature 
searches and expert consultations from step 1, in 
addition to brainstorming within the team. At the 
same time, relevant patient preferences and mo-
derators are identified and assessed in accordance 
with the “Guidance for the assessment of treatment 
moderation and patients' preferences” (Van Hoorn et 
al., 2016). Context and implementation are assessed 
by the application of the “Guidance for the Assess-
ment of Context and Implementation in Health Tech-
nology Assessments (HTA) and Systematic Reviews of 
Complex Interventions: The Context and Implemen-
tation of Complex Interventions (CICI) Framework” 
(Pfadenhauer et al., 2016). The assessment results 
regarding context, implementation issues and pati-
ent characteristics based on the literature and SAP 
consultations feed into the initial logic model. Thus, 
the assessment aspects (dimension 1) and modifying 
factors (dimension 2) are integrated within this logic 
model (Figure 7 as illustrating example).
The SAPs (dimension 4) contribute their perspecti-
ves regarding the contents of the initial logic model. 
The stakeholders and the HTA researchers review the 
initial logic model and provide feedback on its’ plau-
sibility. Accordingly, the HTA objective, including the 
definition of specific technologies, the relevant issu-
es of interest, outcome parameters to be assessed, 
patient preferences and moderators, context and im-
plementation issues, will be refined.
The output of this step is an initial logic model for 
the health technologies of interest. This logic model 
will be used as a conceptual framework to guide the 
data collection of individual assessment aspects (di-
mension 1) in step 3 (e.g. patient preferences can 
inform the search strategy for effectiveness outcome 
parameters). 
If the logic model provides new aspects that need 
to be considered in the HTA objective, the research 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































1 and step 2 of the INTEGRATE-HTA Model thereby de-
fine a comprehensive scope for the HTA.
Example – Specific logic model for the 
INTEGRATE-HTA case study on palliative 
care 
A specific logic model was developed for reinforced 
and non-reinforced models of home-based palliati-
ve care as the technology and comparator of choice 
for the HTA research question. The information was 
assembled from consulting with the SAPs and consul-
tation of palliative care literature and international 
palliative care experts. Figure 7 shows the specific lo-
gic model for reinforced and non-reinforced models 
of home-based palliative care (for details see: “Inte-
grated assessment of home based palliative care with 
and without reinforced caregiver support: ‘A demons-
tration of INTEGRATE-HTA methodological guidances”) 
(Brereton et al., 2015). 
4.3 STEP 3: EVIDENCE ASSESSMENT
 
The initial logic  model from step 2 is applied as a con-
ceptual framework guiding the evidence assessment 
in step 3. The evidence is collected with reference to 
the identified patient preferences and moderators, 
context and implementation issues, relevant issues of 
interest (e.g. continuity of care), specific technologies 
and outcome parameters that are outlined in the logic 
model. The evidence assessment is guided by applying 
the methodological INTEGRATE-HTA guidances pro-
duced for specific assessment aspects (see “Guidance 
for assessing effectiveness, economic aspects, ethical 
aspects, socio-cultural aspects and legal aspects in 
complex technologies” (Lysdahl et al., 2015)).
Depending on the specific assessment aspects, there 
are various sources of evidence and scientific methods 
for the evidence assessment, such as meta-analysis 
for effectiveness outcomes or the Socratic approach 
for ethical outcomes. An important aspect of step 3 is 
to elaborate on how the different assessment aspects 
are interrelated. Continuous collaboration between 
the various assessment processes is essential to avoid 
redundancies (such as between the socio-cultural and 
the ethical assessment).
Finally, the assessment results are reviewed by HTA ex-
perts and SAPs (dimension 4). The outputs of step 3 
are evidence reports for each assessment aspect (e.g. 
report on economics, report on ethical aspects, etc.). 
Thus, the evidence reports integrate the assessment 
results for individual aspects (dimension 1) and the 




Evidence reports and evi-
dence summaries for each 
assessment aspect
Specific requirements and evidence needs 
according to the specific logic model, con-
text, implementation and patient groups 
(moderators/preferences), relevant issues 
Evidence collection for all assessed as-
pects (effectiveness, economics, ethical, 
legal, cultural, and social aspects, rele-
vant issues) 
Assessment of evidence according to
the specific assessement methods
Review of the assessment results by




ment aspects (e.g. effecti-
veness, ethics)
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Figure 11: Structure of HTA aspects for the evidence summary.
degree of uncertainty (dimension 3) that needs to be 
assessed.
Additionally, the HTA researchers present the assess-
ment results for each assessment aspect as standardi-
zed evidence summaries. The evidence summaries are 
not primarily designed for presentation to stakehol-
ders, decision makers or end users of HTA. The purpose 
of this tool is to provide a transparent and operatio-
nal overview of the assessment results, which were 
structured according to assessment criteria of the HTA 
objective outlined in step 1. This tool is further descri-
bed in the following section. 
4.3.1 Completing the evidence  
summary template 
4.3.1.1 Evidence Summaries
HTA researchers complete the evidence summaries 
to provide a concise overview of the results for each 
assessment aspect (i.e. regarding effectiveness, so-
cio-cultural, ethical, economic and legal aspects, 
patient preferences, moderators, context and imple-
mentation issues). The evidence summaries separate 
the results for each assessment aspect into the out-
comes  that have been assessed following the simi-
lar concept of GRADE. We use the term “assessments 
results” for describing both quantitative assessment 
Assessment aspect




5  Applicability 
on the situation 
under question
4  Internal vali-
dity, soundness  
and consistency 
of evidence
3  Relevance of 
the assessment 
results in com-
parisson to other 
technologies
2  Specific im-
portance in the 
disease context
results (such as mortality, morbidity, quality of life for 
effectiveness) as well as qualitative assessment results 
(such as vulnerability as result of the ethical assess-
ment). The evidence summary template is provided in 
the appendix (chapter 7.3).
The evidence summaries for each assessment aspect 
consist of 5 items as illustrated in Figure 11. 
1. General importance of assessment aspect/ outco-
mes for health care: This item describes the overall 
importance of a certain aspect. A general descrip-
tion of the assessment aspect and the outcomes 
should be provided independent of the assessed 
technology. 
Example: If results of the effectiveness assess-
ment are reported, the importance of effective-
ness, including the outcomes assessed such as 
place of death in palliative care, needs to be de-
scribed in a generic manner.
2. Specific importance of the assessment aspect/ out-
comes in disease context: The importance of the as-
sessment aspect and the related outcomes should 
be presented in the disease context (e.g. terminal 
diseases relevant for palliative care). The informati-
on should outline the relevance of the assessments 
results for the specific disease context, such as the 
severity of disease and the population affected. 
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Table 3: Evidence summary template for each assessment aspect.
1  General importance of assessment aspect 
for health care / General description of the 
assessed outcome
2  Specific importance of the assessed outco-
me in disease context
3a  Relevance of each assessed outcome taking 
the technology of interest and a compa-
rator into account (including effects for 
subgroups)
3b  Influence of modifying factors (context, 
implementation issues and patient charac-
teristics) on the assessed outcomes
4  Quantitative results: Internal validity, 
uncertainty and consistency of evidence / 
Qualitative results (ethics, socio-cultural, 
legal): Soundness
5  Applicability to the situation under questi-
on / For Step 4: Assignment of the assess-
ments results to the assessment criteria of 
the HTA research question
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Example: Any improvement in pain reduction can 
be regarded as highly important because redu-
cing pain represents an essential aspect for ter-
minal conditions relevant for palliative care.
3. Relevance of assessments results taking the tech-
nology of interest and a comparator into account 
and including modifying factors: The outcomes of 
the assessment should be presented for both the 
technology of interest and the comparator, so that 
comparisons can be made (point 3a). This infor-
mation should outline the magnitude of an effect 
(where possible) such as a benefit in survival of 6 
months for the technology of interest vs. 3 months 
for the comparator. Additionally, the influence of 
modifying factors (context, implementation issues 
and patient characteristics) on the assessed outco-
mes should be outlined (point 3b).
Example: The assessment of effectiveness showed a 
potential improvement in manageability for caregi-
vers for reinforced models compared to home-ba-
sed models (point 3a). As modifying factor, caregi-
ver competence had a positive effect on caregivers‘ 
feeling of manageability (point 3b). Thus, it (should 
be) assessed whether inter ventions seeking to im-
prove caregiver competence, e.g. the included COPE 
(Creativity, Optimism, Planning, and Expert Infor-
mation) interventions, have a stronger effect for 
caregiver manageability than those reinforced mo-
dels not aiming to improve caregiver competence.
4. Internal validity, soundness and consistency of evi-
dence need to be openly reported. The evidence 
should be reported in line with scientific standards. 
This includes consideration of uncertainty (such as 
conflicting results across studies, limited number of 
studies and patients) and the extent to which re-
porting of evidence on the proposed technology is 
complete and consistent. For qualitative assessment 
aspects, the soundness of arguments needs to be 
considered. 
Example: Only two observational studies with li-
mited statistical power could provide evidence for 
quality of life. As such, the internal validity of the 
evidence is low and this has to be considered during 
decision-making. 
5. Applicability to the situation under question 
describes the extent to which evidence on the 
proposed technology is relevant for the decisi-
on setting (in terms of population, disease stage, 
comparator technologies, outcomes etc.). 
Example: Effectiveness outcomes of a particular 
study cannot be transferred to a specific decisi-
on context if the study population is significantly 
different (e.g. results from a palliative care study 
for children cannot be simply transferred to the 
care of adults).
4.3.1.2 Additional box as preparation for step 4
As outlined in step 1, the researchers responsible 
for the assessment of individual aspects of the HTA 
assigned their results to the assessment criteria of 
the HTA objective. For instance, “Vulnerability”, as 
an assessment result from the ethical assessment, 
was assigned by the HTA researcher to the assess-
ment criterion “Meaningfulness” of the HTA objec-
tive. A second researcher checks all assignments 
made to identify overlaps in the assessments results 
provided by evidence summaries from different 
assessment aspects (such as evidence for “patient 
autonomy” provided by both the legal and ethical 
assessments). 
Example – Evidence Collection for the IN-
TEGRATE- HTA case study on palliative care 
Separate assessments were conducted for the speci-
fic assessment aspects. The evidence summary be-
low (Table 4) illustrates the assessment results for 
the effectiveness of reinforced palliative home care 
for patients in the case study on palliative care (for 
details see: “Integrated assessment of home based 
palliative care with and without reinforced caregi-
ver support: ‘A demonstration of INTEGRATE-HTA me-
thodological guidances’”) (Brereton et al., 2016).
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1  General importance of as-
sessment aspect for health 
care / General description of 
the assessed outcome
Effectiveness describes the capacity of the assessed intervention to produce a desired 
(beneficial) change in signs, symptoms or course of the targeted condition, pati-
ent-reported outcomes (PROs) (e.g., quality of life, convenience to patient) and harm-
ful or undesired health effects, compared to alternative interventions.
1.  Pain describes an unpleasant feeling associated with actual or potential tissue 
damage. Pain and relief therefrom is measured using a very wide range of scales 
and questionnaires.
2.  Symptom control describes the ability to control symptoms by the proposed inter-
vention. Depending on the assessed condition, there is a large range of symptoms. 
3.  Quality of life is the general/health related well-being of individuals. Quality of 
life is measured using a wide range of disease specific scales, questionnaires and 
tools.
4.  Psychological health describes the psychological well-being, or an absence of a 
mental disorder. Consequently, this may be measured through scales addressing 
depression, anxiety, worry, mood, etc. 
5.  Death at home is generally measured as a proportion of those patients who died 
at home, compared to those who died in hospitals or nursing homes.
6.  Hospitalization is a measure of how much time a patient spends in the hospital. 
This can be as a proportion of total time spent in home-based care in the last 2 
months, 1 month or 2 weeks of life. It can include all admissions to hospital or 
only emergency department visits.
7.  Response outcomes highlight which services empower patients to be more prepa-
red patients through education and teaching, to improve self-care, problem-sol-
ving.
8.  Satisfaction with care measures how satisfied patients are with care, how well 
they perceive they are being cared for, and how effective they perceive care to be.
2     Specific importance of the 
assessed outcome in disease 
context
1.  Pain – many palliative patients suffer from pain at the end of life. Considerable 
patient burden at the end of life may be due to pain, and it is therefore import-
ant for services to address this. 
2.  Symptom control – similar to pain, palliative patients suffer from a range of 
symptoms at the end of life. It is important for patient-focused services to help 
relieve patients from the suffering due to symptoms. 
3.  Quality of life – pain, symptoms, social and existential problems can significantly 
decrease quality of life at the end of life. Home-based palliative care services 
should improve quality of life by relieving pain and symptoms, as well as allo-
wing patients to remain at home should they so wish. 
4.  Psychological health – pain, symptoms, social and existential problems may 
lead to a grave psychological burden for patients. As problems experienced at 
the end of life negatively influence psychological health, how services work to 
counteract this effect should be measured. 
5.  Death at home – home-based services should aim to help patients die at home 
should they so wish. 
6.  Hospitalization – home-based services should aim to help patients remain at 
home during the end of life should they so wish. Patients should be enabled to 
spend more time at home during the end of life.
7.  Response – If interventions aim to empower palliative care patients by teaching 
them certain skills, the effectiveness of this should be measured.
8.  Satisfaction – if patient perception of home care is important for effectiveness, 
then this should be investigated.
Table 4: Evidence summary for effectiveness on patient outcomes.
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3a  Relevance of each assessed 
outcome taking the techno-
logy of interest and a com-
parator into account (inclu-
ding effects for subgroups)
1.  Pain – Only one study measured patient pain, and the intervention had a neutral effect.
2.  Symptom control – 5 studies measured patient symptom control; 2 of these showed a 
beneficial intervention effect, and 3 showed a neutral effect.
3.  Quality of Life – measured in 3 studies, all of which showed a neutral effect.
4.  Psychological health – 2 studies provided 4 measures; 2 showed a beneficial interven-
tion effect and 2 a neutral effect.
5.  Death at home – No studies measured death at home.
6.  Hospitalization – measured in 2 studies, both of which showed a neutral effect.
7.  Response – 2 studies provided 3 measures; all of which showed a neutral effect.
8.  Satisfaction – measured in 1 study, which showed a neutral effect.
3b  Influence of modifying fac-
tors (context, implementa-
tion issues and patient cha-
racteristics) on the assessed 
outcomes
Moderators of treatment outcome: Few studies identified in the literature discussed 
moderators relating to caregivers; some evidence pointed to the fact that caregiver 
competence had a positive effect on caregivers’ feeling of manageability. From the 
subset of interventions included in the effectiveness assessment, those known as 
COPE (Creativity, Optimism, Planning, and Expert Information) interventions, were de-
signed to help caregivers develop skills and competencies for caregiving. Because of 
this, a post hoc subgroup analysis was performed, assessing whether COPE interven-
tions improved caregiver outcomes. With the limited evidence available, however, no 
visible difference in effectiveness trend seems present between COPE and non-COPE 
interventions.
Context: The geographical domain of context, e.g. whether patients and caregivers 
are located in urban or rural areas, is potentially also a modifying factor for effecti-
veness. We, therefore, performed a post hoc subgroup analysis, by separating studies 
based on whether they were conducted with patients and caregivers from urban or 
rural areas. Only 2 out of the included 10 studies explicitly enrolled participants from 
rural areas, but in both of these studies, a majority urban participants was also in-
cluded. This in itself is a result, and highlights the need for the implementation and 
evaluation of such programs in rural areas.
4    Quantitative results: Inter-
nal validity, uncertainty and 
consistency of evidence
Qualitative results (ethics, 
socio-cultural, legal): 
Soundness 
Internal validity: Most of the included studies are RCTs, but as common in palliative care 
research, investigators had significant problems in recruiting and retaining patients in the 
trials. Further, earlier than expected death led to low power in many of the studies. 
The criteria used to judge risk of bias were taken from the Cochrane Effective Practice and 
Organization of Care (EPOC) Group (see full evidence report for more details).
Uncertainty: Only 6 studies measured patient outcomes, and 5 of those only measured a 
narrow range of outcomes. Certain outcomes, which may be considered important – e.g. 
the effect on patient satisfaction with care, the effect on hospitalization and death at 
home – were measured very rarely, if at all. The effects of included reinforced services on 
these outcomes remain uncertain.
Consistency: Little consistency is seen as most of the evidence points towards a neutral 
effect, with the rest mainly favoring the intervention. There is little evidence (1 study for 
1 outcome) pointing towards an effect favoring the control.
5    Quantitative results: External 
validity of evidence, gene-
ralizability, applicability or 
 
Qualitative results (ethics, 
socio-cultural, legal): Rele-
vance
The evaluated reinforced and non-reinforced services were implemented in a variety of 
settings – with regard to country, geography, healthcare system. How this would influen-
ce the implementation of certain services in England should be considered.
A few studies included in the effectiveness assessment were conducted in England, and 
the evidence from these studies should be generalizable to the rest of England.
For Step 4: Assignment of 
the assessment results to 
the assessment criteria of 
the HTA research question
All assessment results should be assigned to the assessment criterion “Effectiveness”.
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4.4 STEP 4: MAPPING OF THE  
EVIDENCE
   
Step 4 processes and organizes the assessment results 
that have been generated in step 3 of the INTEGRATE- 
HTA Model. The evidence summaries from step 3 are 
assigned to the respective assessment criteria of the 
HTA objective (such as “Meaningfulness”, “Accepta-
bility” see 4.3.1.2). Finally, the initial logic model 
created in step 2 provides the structure for the ex-
tended logic model to assist decision making. The 
extended logic model to assist decision making is 
a new tool that was developed in this project to 
enable a comprehensive, transparent and integ-
rated illustration of all assessment results. It is a 
graphical way of informing decision makers about 
aspects related to the technologies of interest and 
identified as relevant for their benefit according to 
the HTA objective. The following sections describe 
how the assessment results are restructured (4.4.1) 
to construct the extended logic model to assist de-
cision making (4.4.2).
4.4.1  Integration of the assessment 
results into the final logic model
The assessment results are entered into the initial 
logic model from step 2, to obtain a final logic 
model. Where an assessment result consists of evi-
dence from more than one assessment aspect (such 
as evidence for “patient autonomy” was provided 
by the legal and ethics assessments), it is assigned 
to multiple areas in the final logic model (in this 
case, the legal and ethical context). 
4.4.2  Construction of the extended logic 
model to assist decision-making
HTA researchers process the evidence summaries 
from step 3 to provide integrated answers to the 
HTA objective. In step 3, the HTA researchers assign 
the assessment results from the evidence sum-
maries to the relevant assessment criteria of the 
HTA objective defined in step 1. A summary table 
for each assessment criterion of the HTA objective 
is developed. For each summary table, the “Gui-
dance on choosing qualitative evidence synthesis 
methods for use in health technology assessments 
of complex interventions” (Booth et al., 2016) 
supports the synthesis of the evidence obtained 
from the various assessment aspects. As a result, 
Figure 12: Step 4: Mapping of the evidence.
RESULT
Mapping of the  
evidence
Step 4
Extended logic model and 
synthesised evidence ac-
cording to the HTA research 
question
Evidence summaries about different
assessment aspects  
(e.g. effectiveness, ethics) 
Integration of the assessment results  
(effectiveness, ethics etc.)  
into a final logic model
Construction of the extended logic
model to assist decision-making:
Summarizing and structuring the
assessment results into specific
assessment criteria of the HTA
research question
 Plausibility check by stakeholders
(HTA researchers, SAPs)
 Deriving conclusions from the extended 
logic model with regard to the specific 
decison context (HTA researchers, SAPs, 
decision-maker) 
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the summary tables provide decision makers with 
a concise overview of the assessment results that 
specifically answer the HTA objective (illustrating 
example in Figure 13). 
The summary tables and the final logic model pro-
vide the structure of the extended logic model to 
assist decision-making. In addition, the assess-
ment criteria of the HTA objective feed into the 
extended logic model. The criteria are coded with 
symbols at the bottom of the extended logic mo-
del to assist decision-making. All assessment re-
sults relating to the same assessment criterion are 
coded with the same symbol (Illustration example: 
Figure 10). If an assessment result is assigned to 
multiple assessment criteria of the HTA objective 
(as outlined in 4.3.1.2), it will be coded with mul-
tiple symbols accordingly.
4.4.3 Plausibility check
Finally, the extended logic model should be pre-
sented to the SAPs (representing dimension 4) who 
should be asked about the plausibility and the 
usefulness of information provided. The feedback 
should feed into the final version. The summary 
tables (4.4.2) should be read in conjunction with 
the extended logic model to assist decision-ma-
king.
4.4.4 Conclusions derived from the 
extended logic model to assist 
decision-making
Presented as a “Table of content” of the assess-
ment results, the extended logic model to assist 
decision-making (step 4) and the evidence reports 
(step 3) enable a detailed evaluation of benefits 
and drawbacks of each assessed technology. In 
addition, the extended logic model can be used 
for a structured applicability assessment regarding 
the implementation of the health technology in a 
specific setting (Brereton et al., 2015). The exten-
ded logic model thereby outlines the contextual 
and implementation factors, which will have been 
identified for the various HTA aspects in steps 2 
and 3 of the INTEGRATE-HTA Model. The SAPs can 
evaluate these factors regarding the applicability 
and transferability of the health technology to a 
specific setting.
Example – Processing the Evidence 
in the INTEGRATE-HTA case study on 
palliative care 
The assessment results were extracted from the 
evidence summaries of the different assessment 
aspects (e.g. effectiveness, legal aspects, etc.; 
example in step 3) and were assigned to the six 
assessment criteria of this specific HTA objecti-
ve (see Figure 13). The HTA objective for the case 
study on palliative care was: “Are reinforced home 
care models of palliative care acceptable, feasible, 
appropriate, meaningful, effective, cost-effective 
for providing patient-centred palliative care [com-
pared to usual home care models of palliative care] 
in adults (defined as those aged 18 years old and 
over) and their families?” 
Finally, the assessment results were visualized in 
the extended logic model to assist decision-making 
as presented in Figure 14. For instance, the assess-
ment result “Autonomy and shared decision-ma-
king” was dealt within three different assessment 
aspects (legal, ethics, socio-cultural aspects) and 
one modifying factor (patient preferences). 
The assignment of assessment results to certain as-
sessment criteria is coded with symbols: 
   Effectiveness = square; 
   Cost-effectiveness = star; 
   Acceptability = triangle; 
   Meaningfulness = circle; 
   Feasibility = diamond; 
    Appropriateness = pentagon
In addition, the sources of evidence are outlined 
using numbers: 
1 = Guidance for the assessment of effectiveness, 
and economic, ethical, socio-cultural, and legal is-
sues of complex technologies 
2 = Guidance for the assessment of treatment mo-
deration and patients’ preferences
3 = Guidance for the Assessment of Context and 
Implementation in Health Technology Assessments 
(HTA) and Systematic Reviews of Complex Interven-
tions: The Context and Implementation of Complex 
Interventions (CICI) Framework
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Figure 13: Assignment of the assessment results to the assessment criteria of the HTA objective.
ﬁ Caregiver
ﬁ Quality of life
ﬁ Response Outcomes
ﬁ Satisfaction with care









ﬁ Satiscfaction with care
ﬁ Death at home (plus preferences) 
  EFFECTIVENESS  
ﬁ Costs per patient
ﬁ Resources impact (e.g. Specialist 
Nurse time)
ﬁ Budget impact
  ECONOMICS  
ﬁ Changing roles and relationships 
for caregiver (ethical)
ﬁ Changing roles and relationships 
for patients (ethical)
ﬁ Autonomy and shared decision 
making (legal, ethical, preferences) 
ﬁ Location of death (preferences) 
ﬁ Preference for survival
  ACCEPTABILITY
ﬁ Vulnerability (ethical)
ﬁ Perceived usefulness and the idea 
of benefit (socio-cultural)
ﬁ Knowledge and understanding of 
the technology (i.e. home-based 
palliative care, socio-cultural)
ﬁ User-professionals-relationships 
and decision making (socio- 
cultural)
  MEANINGFULNESS
ﬁ Context and implementation issues  
  FEASIBILITY 
ﬁ Access and availability (ethical)
ﬁ Voluntariness (ethical)














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































4.5 STEP 5: HTA DECISION- 
MAKING
 
The purpose of this step is to analyze the HTA results 
in order to come to a decision. The decision making 
process should be performed by a decision panel in-
cluding the HTA commissioners and the corresponding 
decision-making body, and possibly the stakeholders 
involved in the HTA process.
This final step is based on the evidence reports (step 
3) and the visualization of the extended logic model 
to assist decision-making in step 4, including the HTA 
conclusions derived from the model and an analysis in 
terms of the performance of the health technology on 
the different assessment criteria of the HTA objective. It 
should support the members of the decision panel (di-
mension 4) to conduct a deliberative discussion. As such, 
the decision committee should actively reflect on the as-
sessment results of the different assessment aspects (di-
mension 1), the degree of uncertainty (dimension 2) and 
the impact of the modifying factors (dimension 3) that 
are relevant for their specific decision context.
A decision support tool can be employed to structure 
the discussion of the decision committee. There are 
quantitative methods available, such as MCDA me-
thods, or qualitative approaches such as consensus 
reaching processes. A combined approach, where a 
quantitative tool can be applied to certain aspects to 
prepare a qualitative discussion can also be envisa-
ged. Flexibility in the application of these tools is cru-
cial, taking different decision settings and evidence 
needs into consideration.
(a)  MCDA approaches can be used to quantify the im-
portance of the assessment criteria and the rele-
vance assigned to specific assessment results (see 
integrative technique 5 in the appendix). MCDA in 
this case would not be used as a formula to come 
to a decision, but rather as a tool to make the 
values and viewpoints of decision makers trans-
parent and support reflection on their preferences 
related to the range of dimensions in the over-
all assessment of a technology (Wahlster et al., 
2015a).
(b) Several approaches to guide deliberative deci-
sion-making processes e.g. consensus reaching 
processes were identified. Consensus Reaching 
Processes (DeGroot, 1974; Eisenberg & Gale, 1959; 
Palomares et al., 2014) describe a variety of me-
thods to measure the distances between different 
expert opinions or between individual and collec-
tive opinions. A feedback mechanism intends to 




HTA decision /  
recommendation
Presentation of HTA results ob-
tained from steps 3 and 4 to a 
decision committee comprising 
stakeholders/decision-makers
Selecting a tool to structure a
deliberative discussion (in




about unanswered issues / uncer-
tainty / limitations of the assess-











































































































































































































































































































































































































































































































































































































































decrease these differences (numerical, intervals or 
linguistic) to achieve consensus for the final HTA 
decision.
Furthermore, the evidence that is restructured into sum-
mary tables according to the assessment criteria of the 
HTA objective (see 4.4.2) provides an additional structure 
for the final deliberative discussion. Based on these out-
puts, the SAPs can focus on the results assigned to one 
assessment criterion at a time. Following this, the decision 
panel can reflect on unanswered issues (perhaps because 
these issues won’t have been raised yet), limitations of the 
HTA methods used, the HTA process applied, and uncer-
tainty surrounding the HTA results. In keeping with step 1, 
this final discussion is flexible to allow adaptation of the 
decision-making process to different political decision set-
tings in different countries. All dimensions are integrated 
to obtain a final HTA decision at the end of this step.
Example – Decision-Making in INTEGRATE- 
HTA case study on palliative care
For step 5 of the INTEGRATE-HTA case study, we selected a 
simple MCDA approach (based on the EVIDEM rating me-
thods). Different lay and professional stakeholders with 
different backgrounds (e.g. physicians, service commissi-
oners, former caregivers) joined a mock decision meeting. 
Based on the MCDA results, the participants identified 
important issues regarding HTA recommendations about 
reinforced models of palliative home care in the final deli-
berative discussion (for details see “Integrated assessment 
of home based palliative care with and without reinforced 
caregiver support: ‘A demonstration of INTEGRATE-HTA me-
thodological guidances”) (Brereton et al., 2015).
 
5 CONCLUSIONS
The final impact of a complex health technology is affected 
by a broad range of interacting factors. These factors inclu-
de effectiveness, economic, socio-cultural, legal and ethical 
aspects, as well as patient characteristics and context and 
implementation issues. An integrated perspective on these 
assessment aspects is important for the appraisal in health 
care decision-making. 
We developed the INTEGRATE-HTA Model to address these 
issues. The model comprises five steps: After an initial defi-
nition of the HTA objective and the technology in accordance 
with the support of the stakeholders in step 1, the initial 
logic model in step 2 provides a structured overview of the 
factors and aspects around the technology. Patient charac-
teristics, context and implementation issues feed into the 
assessment of effectiveness, and economic, ethical, legal, 
and socio-cultural aspects. Results of the assessments are 
structured by the HTA objective and feed into the extended 
logic model to assist decision-making. Finally, the results 
presented in this way form the basis of a structured decisi-
on-making process. 
5.1 STRENGTHS AND LIMITATIONS 
OF THE INTEGRATE-HTA  
MODEL
The strength of the INTEGRATE-HTA Model is that it addres-
ses all relevant dimensions of information in HTA of com-
plex technologies, and that it frames integration throug-
hout the assessment process and not only at the end. It 
addresses the methodological and content-related inter-
dependencies between the different assessment aspects, 
taking patient characteristics, implementation issues and 
context and the uncertainties of information (dimension 
3) into consideration. Stakeholders’ values and informati-
on needs (dimension 4) are integrated in each step of the 
INTEGRATE-HTA Model. The participation of stakeholders 
throughout the INTEGRATE-HTA Model also ensures com-
prehensiveness and relevance of the results. 
Our approach has some limitations. Usually HTA values 
rigid protocols and pre-defined objectives. In our model 
(sub-) objectives might need adaption during the process. 
Hence, the model needs time, expertise in different areas, 
major coordination and communication skills, flexibility, 
and building up a network with stakeholders. The success 
of integration is limited by the extent to which different 
assessment methods are harmonized to each other. The 
terminology and definitions used need to match between 
the assessment methods to truly integrate the assessment 
results. 
In sum, we expect that the INTEGRATE-HTA Model can be 
applied for the assessment of most complex technologies 
in various health care systems and settings.
 
5.2  OUTLOOK
The INTEGRATE-HTA Model applies different integrative 
techniques to address various methodological, structural 
and organizational challenges associated with an integra-
ted assessment of complex technologies. The INTEGRATE-HTA 
Model can feed into the further development of HTA pro-
cesses of complex technologies. The more complex future 
health technologies will get, the more issues about integra-
tion of information will gain further importance. One of the 




ALLEN, J., DYAS, J., JONES, M. (2004) Building consensus in health care: a guide to using the nominal group 
technique. Br J Community Nurs, 9, 110-114.
ANDERSON, L.M. (2011) Using logic models to capture complexity in systematic reviews. Research Synthesis Me-
thods, 2, 33-42.
ANDERSON, L.M., PETTICREW, M., REHFUESS, E., ARMSTRONG, R., UEFFING, E., BAKER, P., FRANCIS, D., TUGWELL, P. 
(2011) Using logic models to capture complexity in systematic reviews. Research Synthesis Methods, 
2, 33-42.
AOUNI, B., KETTANI, O. (2001) Goal programming model: A glorious history and a promising future. European 
Journal of Operational Research, 133, 225-231.
ARUNRAJ, N.S., MANDAL, S., MAITI, J. (2013) Modeling uncertainty in risk assessment: an integrated approach 
with fuzzy set theory and Monte Carlo simulation. Accident Analysis & Prevention, 55, 242-255.
ATKINS, D., BEST, D., BRISS, P.A., ECCLES, M., FALCK-YTTER, Y., FLOTTORP, S., GUYATT, G.H., HARBOUR, R.T., HAUGH, M.C., 
HENRY, D., HILL, S., JAESCHKE, R., LENG, G., LIBERATI, A., MAGRINI, N., MASON, J., MIDDLETON, P., MRU-
KOWICZ, J., O‘CONNELL, D., OXMAN, A.D., PHILLIPS, B., SCHÜNEMANN, H.J., EDEJER, T., VARONEN, H., VIST, 
G.E., WILLIAMS, J.W., ZAZA, S., GRADE WORKING GROUP (2004) Grading quality of evidence and strength 
of recommendations. BMJ, 328, 1490.
AXELROD, R. (2015) Structure of decision: The Cognitive Maps of Political Elites. New Jersey: Princeton University 
Press.
BACK-PETTERSSON, S., HERMANSSON, E., SERNERT, N., BJORKELUND, C. (2008) Research priorities in nursing--a De-
lphi study among Swedish nurses. J Clin Nurs, 17, 2221-2231.
BANA E COSTA, C.A., VANSNICK, J.-C. (1999) The MACBETH Approach: Basic Ideas, Software, and an Application. In: 
MESKENS, N., ROUBENS, M. (eds.). Advances in Decision Analysis. Netherlands: Springer Netherlands.
BASHEER, I.A., HAJMEER, M. (2000) Artificial neural networks: fundamentals, computing, design, and applicati-
on. Journal of Microbiological Methods, 43, 3-31.
BAXTER, S., KILLORAN, A., KELLY, M.P., GOYDER, E. (2010) Synthesizing diverse evidence: the use of primary quali-
tative data analysis methods and logic models in public health reviews. Public health, 124, 99-106.
BAYES, T., PRICES, M. (1763) An Essay towards Solving a Problem in the Doctrine of Chances. By the Late Rev. 
Mr. Bayes, F. R. S. Communicated by Mr. Price, in a Letter to John Canton, A. M. F. R. S. Philosophical 
Transactions (1683-1775), 53, 370-418.
BELL, D. (2005) Graded relative evidence. Artificial Intelligence Review, 23, 155-184.
BELTON, V., STEWART, T. (2002) Multiple Criteria Decision Analysis - An integrated approach. Dordrecht: Kluwer 
Academic Publishers.
BERRA, S., SANCHEZ, E., PONS, J.M., TEBE, C., ALONSO, J., AYMERICH, M. (2010) Setting priorities in clinical and 
health services research: properties of an adapted and updated method. Int J Technol Assess Health 
Care, 26, 217-224.
BEYNON, M., CURRY, B., MORGAN, P. (2000) The Dempster–Shafer theory of evidence: an alternative approach to 
multicriteria decision modelling. Omega, 28, 37-50.
| 40 
BOOTH, A., NOYES, J., FLEMMING K., GERHARDUS, A., WAHLSTER, P., VAN DER WILT, G.J., MOZYGEMBA, K., REFOLO P., 
SACCHINI, D., TUMMERS, M., REHFUESS, E. (2016) Guidance on choosing qualitative evidence synthesis 
methods for use in health technology assessments of complex interventions. [Online]. Available from: 
http://www.integrate-hta.eu/downloads/ 
BRANS, J.P., VINCKE, P., MARESCHAL, B. (1986) How to select and how to rank projects: The Promethee method. 
European Journal of Operational Research, 24, 228-238.
BRERETON, L., WAHLSTER, P., LYSDAHL, K.B., MOZYGEMBA, K., BURNS, J., CHILCOTT, J.B., WARD, S., BRÖNNEKE, J.B., 
TUMMERS, M., VAN HOORN, R., PFADENHAUER, L., POLUS, S., INGLETON, C., GARDINER, C., VAN DER WILT, 
G.J., GERHARDUS, A., ROHWER, A., REHFUESS, E., OORTWIJN, W., REFOLO, P., SACCHINI, D., LEPPERT, W., 
BLAZEVICIENE, A., SPAGNOLO A.G., PRESTON, L., CLARK, J., GOYDER, E., ON BEHALF OF THE INTEGRATE-HTA 
TEAM (2016) Integrated assessment of home based palliative care with and without reinforced caregi-
ver support: ‘A demonstration of INTEGRATE-HTA methodological guidances’ [Online]. Available from: 
http://www.integrate-hta.eu/downloads/ 
BRINK, T.L. (1994) R.L. Keeney, H. Raiffa: Decisions with multiple objectives–preferences and value tradeoffs, 
Cambridge University Press, Cambridge & New York, 1993, 569 pages, ISBN 0-521-44185-4 (hard-
back), 0-521-43883-7 (paperback). Behavioral Science, 39, 169-170.
CANADIAN AGENCY FOR DRUGS AND TECHNOLOGIES IN HEALTH (CADTH) (2006) Guidelines for the economic evaluation 
of health technologies. (3 ed). Ottawa: Canadian Agency for Drugs and Technologies in Health.
CARO, J.J., NORD, E., SIEBERT, U., MCGUIRE, A., MCGREGOR, M., HENRY, D., DE POUVOURVILLE, G., ATELLA, V., KO-
LOMINSKY-RABAS, P. (2010) The efficiency frontier approach to economic evaluation of health-care 
interventions. Health Economics, 19, 1117-1127.
CARRICO, N., COVAS, D.I., ALMEIDA, M.C., LEITAO, J.P., ALEGRE, H. (2012) Prioritization of rehabilitation interven-
tions for urban water assets using multiple criteria decision-aid methods. Water Sci Technol, 66, 
1007-1014.
CHARNES, A., COOPER, W.W. (1957) Management Models and Industrial Applications of Linear Programming. Ma-
nagement Science, 4, 38-91.
CHARNES, A., COOPER, W.W., FERGUSON, R.O. (1955) Optimal Estimation of Executive Compensation by Linear Pro-
gramming. Management Science, 1, 138-151.
CHENG, S., CHAN, C.W., HUANG, G.H. (2002) Using multiple criteria decision analysis for supporting decisions of 
solid waste management. J Environ Sci Health A Tox Hazard Subst Environ Eng, 37, 975-990.
CLAXTON, K., NEUMANN, P.J., ARAKI, S., WEINSTEIN, M.C. (2001) Bayesian Value-of-Information Analysis. Internati-
onal Journal of Technology Assessment in Health Care, 17, 38-55.
COAST, J. (2004) Is economic evaluation in touch with society‘s health values? BMJ, 329, 1233-1236.
CONRAD, K.J., RANDOLPH, F.L., KIRBY, M.W., BEBOUT, R.R. (1999) Creating and Using Logic Models. Alcoholism Tre-
atment Quarterly, 17, 17-31.
COOPER, N., COYLE, D., ABRAMS, K., MUGFORD, M., SUTTON, A. (2005) Use of evidence in decision models: an 
appraisal of health technology assessments in the UK since 1997. Journal of Health Services & Rese-
arch Policy, 10, 245-250.
CORRO RAMOS, I., RUTTEN-VAN MOLKEN, M.P., AL, M.J. (2013) The role of value-of-information analysis in a health 
care research priority setting: a theoretical case study. Med Decis Making, 33, 472-489.
CRAIG, P., DIEPPE, P., MACINTYRE, S., MICHIE, S., NAZARETH, I., PETTICREW, M. (2008) Developing and evaluating 
complex interventions: the new Medical Research Council guidance. BMJ, 337, 587-592.
41 |
CRAMA, Y., HANSEN, P. (1983) An Introduction to the Electre Research Programme. In: HANSEN, P. (ed.). Essays and 
Surveys on Multiple Criteria Decision Making. Berlin Heidelberg: Springer Berlin Heidelberg.
CROSBY, N., KELLY, J.M., SCHAEFER, P. (1986) Citizens Panels: A New Approach to Citizen Participation. Public Ad-
ministration Review, 46, 170-178.
DALKEY, N.C., HELMER-HIRSCHBERG, O. (1962) An Experimental Application of the Delphi Method to the Use of 
Experts.
DEGROOT, M.H. (1974) Reaching a Consensus. Journal of the American Statistical Association, 69, 118-121.
DELBECQ, A.L., VAN DE VEN, A.H. (1971) A Group Process Model for Problem Identification and Program Planning. 
The Journal of Applied Behavioral Science, 7, 466-492.
DEMPSTER, A.P. (1967) Upper and Lower Probabilities Induced by a Multivalued Mapping. The Annals of Mathe-
matical Statistics, 38, 325-339.
DODGSON, J.S., SPACKMAN, M., PEARMAN, A., PHILLIPS, L.D. (2009) Multi-criteria analysis: a manual.  London: 
Department for Communities and Local Government.
EDWARDS, W., BARRON, F.H. (1994a) SMARTS and SMARTER: Improved Simple Methods for Multiattribute Utility 
Measurement. Organizational Behavior and Human Decision Processes, 60, 306-325.
EDWARDS, W., BARRON, F.H. (1994b) SMARTS and SMARTER: Improved Simple Methods for Multiattribute Utility 
Measurement. Organ Behav Hum Decis Process, 60, 306-325.
EISENBERG, E., GALE, D. (1959) Consensus of Subjective Probabilities: The Pari-Mutuel Method. The Annals of 
Mathematical Statistics, 30, 165-168.
FINN, A., LOUVIERE, J.J. (1992) Determining the Appropriate Response to Evidence of Public Concern: The Case of 
Food Safety. Journal of Public Policy & Marketing, 11, 12-25.
FLYNN, T.N., LOUVIERE, J.J., PETERS, T.J., COAST, J. (2007) Best–worst scaling: What it can do for health care rese-
arch and how to do it. J Health Econ, 26, 171-189.
FRIKHA, A. (2014) On the use of a multi-criteria approach for reliability estimation in belief function theory. 
Information Fusion, 18, 20-32.
GOETGHEBEUR, M.M., WAGNER, M., KHOURY, H., LEVITT, R.J., ERICKSON, L.J., RINDRESS, D. (2008) Evidence and 
Value: Impact on DEcisionMaking--the EVIDEM framework and potential applications. BMC Health Serv 
Res, 8, 270.
GOETGHEBEUR, M.M., WAGNER, M., KHOURY, H., LEVITT, R.J., ERICKSON, L.J., RINDRESS, D. (2012) Bridging health 
technology assessment (HTA) and efficient health care decision making with multicriteria decision 
analysis (MCDA): Applying the evidem framework to medicines appraisal. Medical Decision Making, 
32, 376-388.
GOETGHEBEUR, M.M., WAGNER, M., KHOURY, H., RINDRESS, D., GREGOIRE, J.P., DEAL, C. (2010) Combining multicri-
teria decision analysis, ethics and health technology assessment: applying the EVIDEM decision-ma-
king framework to growth hormone for Turner syndrome patients. Cost Eff Resour Alloc, 8, 4.
GOODWIN, E., FREW, E.J. (2013) Using programme budgeting and marginal analysis (PBMA) to set priorities: Re-
flections from a qualitative assessment in an English Primary Care Trust. Social Science & Medicine, 
98, 162-168.
GOPALAKRISHNA, G., MUSTAFA, R.A., DAVENPORT, C., SCHOLTEN, R.J., HYDE, C., BROZEK, J., SCHÜNEMANN, H.J., BOS-
SUYT, P.M., LEEFLANG, M.M., LANGENDAM, M.W. (2014) Applying Grading of Recommendations Assess-
ment, Development and Evaluation (GRADE) to diagnostic tests was challenging but doable. J Clin 
Epidemiol, 67, 760-768.
| 42 
GRABISCH, M. (1995) Fuzzy integral in multicriteria decision making. Fuzzy Sets and Systems, 69, 279-298.
GRABISCH, M., LABREUCHE, C. (2005) Fuzzy Measures and Integrals in MCDA. Multiple Criteria Decision Analysis: 
State of the Art Surveys, 78, 563-608.
GUITOUNI, A., MARTEL, J.-M. (1998) Tentative guidelines to help choosing an appropriate MCDA method. European 
Journal of Operational Research, 109, 501-521.
GULDBRANDSSON, K., STENSTROM, N., WINZER, R. (2015) The DECIDE evidence to recommendation framework ad-
apted to the public health field in Sweden. Health Promot Int [Online]. Available from: http://heapro.
oxfordjournals.org/content/early/2015/06/15/heapro.dav060.full.pdf+html [Accessed: 16.05.2015].
GUYATT, G.H., OXMAN, A.D., KUNZ, R., FALCK-YTTER, Y., VIST, G.E., LIBERATI, A., SCHUNEMANN, H.J. (2008) GRADE: 
going from evidence to recommendations. British Medical Journal, 336, 1049-1051.
HAWKINS, J.W., BURKE, P.J., STEINBERG, S. (2006) Integrating practice issues in managed care into the curriculum: 
a Delphi survey. Journal of the American Academy of Nurse Practitioners, 18, 582-590.
HOEFMAN, R.J., VAN EXEL, J., ROSE, J.M., VAN DE WETERING, E.J., BROUWER, W.B. (2014) A discrete choice experi-
ment to obtain a tariff for valuing informal care situations measured with the CarerQol instrument. 
Medical Decision Making, 34, 84-96.
HOWARD, R.A. (1966) Information Value Theory. Systems Science and Cybernetics, IEEE Transactions on, 2, 22-26.
HSU, J., BROZEK, J.L., TERRACCIANO, L., KREIS, J., COMPALATI, E., STEIN, A.T., FIOCCHI, A., SCHUENEMANN, H.J. (2011) 
Application of GRADE: Making evidence-based recommendations about diagnostic tests in clinical 
practice guidelines. Implementation Science, 6, 1-9.
HUMMEL, M.J., VOLZ, F., VAN MANEN, J.G., DANNER, M., DINTSIOS, C.M., IJZERMAN, M.J., GERBER, A. (2012) Using 
the Analytic Hierarchy Process to Elicit Patient Preferences: Prioritizing Multiple Outcome Measures of 
Antidepressant Drug Treatment. Patient, 5.
HWANG, C.L., YOON, K. (1981) Multiple Attribute Decision Making – Methods and Applications. A State-of-the-Art 
Survey. Berlin - Heidelberg: Springer-Verlag.
INTERNATIONAL NETWORK OF AGENCIES FOR HEALTH TECHNOLOGY ASSESSMENT (IANHTA) 2015. Glossary [Online]. Avai-
lable from: http://www.inahta.org/Glossary [Accessed: 08.07.2015].
JOHNSON, P., BANCROFT, T., BARRON, R., LEGG, J., LI, X., WATSON, H., NAEIM, A., WATKINS, A., MARSHALL, D.A. (2014) 
Discrete Choice Experiment to Estimate Breast Cancer Patients‘ Preferences and Willingness to Pay for 
Prophylactic Granulocyte Colony-Stimulating Factors. Value in Health, 17, 380-389.
KELLOG, W.K. (2004) Using Logic Models to Bring Together Planning, Evaluation, and Action: Logic Model Develop-
ment Guide. Michigan: Kellog foundation.
KLOJGAARD, M.E., MANNICHE, C., PEDERSEN, L.B., BECH, M., SOGAARD, R. (2014) Patient Preferences for Treatment 
of Low Back Pain-A Discrete Choice Experiment. Value in Health, 17, 390-396.
KOCH, K.D. (2010) Proposed methods of the IQWiG for cost-benefit-assessment of medical interventions. Ge-
sundheitswesen, Supplement, 71, 34-40.
LAMPE, K., MAKELA, M., GARRIDO, M.V., ANTTILA, H., AUTTI-RAMO, I., HICKS, N.J., HOFMANN, B., KOIVISTO, J., KUNZ, 
R., KARKI, P., MALMIVAARA, A., MEIESAAR, K., REIMAN-MOTTONEN, P., NORDERHAUG, I., PASTERNACK, I., 
RUANO-RAVINA, A., RASANEN, P., SAALASTI-KOSKINEN, U., SAARNI, S.I., WALIN, L., KRISTENSEN, F.B. (2009) 
The HTA core model: a novel method for producing and reporting health technology assessments. Int 
J Technol Assess Health Care, 25 Suppl 2, 9-20.
LIAO, S.K., CHANG, K.L. (2009) Selecting public relations personnel of hospitals by analytic network process. J 
Hosp Mark Public Relations, 19, 52-63.
43 |
LIBERATORE, M.J., NYDICK, R.L. (2008) The analytic hierarchy process in medical and health care decision making: 
A literature review. European Journal of Operational Research, 189, 194-207.
LOOTSMA, F.A. (1992) The REMBRANDT System for Multi-criteria Decision Analysis via Pairwise Comparisons or 
Direct Rating. Delft University of Technology, The Netherlands: Faculty of Technical Mathematics and 
Informatics.
LYSDAHL, K.B., MOZYGEMBA, K., BURNS, J., CHILCOTT, J.B., BRÖNNEKE, J.B., HOFMANN, B. (2016) Guidance for as-
sessing effectiveness, economic aspects, ethical aspects, socio-cultural aspects and legal aspects in 
complex technologies [Online]. Available from: http://www.integrate-hta.eu/downloads/ 
MAVROTAS, G., ZIOMAS, I.C., DIAKOUAKI, D. (2006) A combined MOIP-MCDA approach to building and screening 
atmospheric pollution control strategies in urban regions. Environmental Management, 38, 149-160.
MCFADDEN, D. (1975) The Revealed Preferences of a Government Bureaucracy: Theory. The Bell Journal of Econo-
mics, 6, 401-416.
MCFADDEN, D. (1976) The Revealed Preferences of a Government Bureaucracy: Empirical Evidence. The Bell Jour-
nal of Economics, 7, 55-72.
MIOT, J., WAGNER, M., KHOURY, H., RINDRESS, D., GOETGHEBEUR, M.M. (2012) Field testing of a multicriteria de-
cision analysis (MCDA) framework for coverage of a screening test for cervical cancer in South Africa. 
Cost Eff Resour Alloc, 10, 2.
MITTON, C., DONALDSON, C. (2001) Twenty-five years of programme budgeting and marginal analysis in the health 
sector, 1974-1999. Journal of Health Services Research & Policy, 6, 239-248.
MITTON, C., PEACOCK, S., DONALDSON, C., BATE, A. (2003) Using PBMA in Health Care Priority Setting: Description, 
Challenges and Experience. Applied Health Economics and Health Policy, 2, 121-127.
MONTIBELLER, G., BELTON, V., ACKERMANN, F., ENSSLIN, L. (2008) Reasoning maps for decision aid: an integrated 
approach for problem-structuring and multi-criteria evaluation. Journal of the Operational Research 
Society, 59, 575-589.
MOORE, G.F., AUDREY, S., BARKER, M., BOND, L., BONELL, C., HARDEMAN, W., MOORE, L., O’CATHAIN, A., TINATI, T., 
WIGHT, D., BAIRD, J. (2015) Process evaluation of complex interventions: Medical Research Council 
guidance. BMJ, 350, 1-7.
MUROFUSHI, T., SUGENO, M. (1989) An interpretation of fuzzy measures and the Choquet integral as an integral 
with respect to a fuzzy measure. Fuzzy Sets and Systems, 29, 201-227.
MUROFUSHI, T., SUGENO, M. (1991) A theory of fuzzy measures: Representations, the Choquet integral, and null 
sets. Journal of Mathematical Analysis and Applications, 159, 532-549.
NATIONAL INSTITUE FOR HEALTH AND CARE EXCELLENCE (NICE) (2013) Guide to the methods of technology appraisal. 
United Kingdom: National Institue for Health and Care Excellence.
PALOMARES, I., ESTRELLA, F.J., MARTÍNEZ, L., HERRERA, F. (2014) Consensus under a fuzzy context: Taxonomy, ana-
lysis framework AFRYCA and experimental case of study. Information Fusion, 20, 252-271.
PAWSON, R., GREENHALGH, T., HARVEY, G., WALSHE, K. 2004. Realist synthesis: an introduction [Online]. Available 
from: http://betterevaluation.org/sites/default/files/RMPmethods2.pdf [Accessed: 19.10.2015].
PEARL, J. (1985) Bayesian Networks: A Model of Self-Activated Memory for Evidential Reasoning.
PFADENHAUER, L., ROHWER, A., BURNS, J., BOOTH, A., LYSDAHL, K.B., HOFMANN, B., GERHARDUS, A., MOZYGEMBA, K., 
TUMMERS, M., WAHLSTER, P., REHFUESS, E. (2016) Guidance for the Assessment of Context and Imple-
mentation in Health Technology Assessments (HTA) and Systematic Reviews of Complex Interventions: 
The Context and Implementation of Complex Interventions (CICI) Framework [Online]. Available from: 
http://www.integrate-hta.eu/downloads/ 
| 44 
POTOGLOU, D., BURGE, P., FLYNN, T., NETTEN, A., MALLEY, J., FORDER, J., BRAZIER, J.E. (2011) Best-worst scaling vs. 
discrete choice experiments: An empirical comparison using social care data. Social Science & Medi-
cine, 72, 1717-1727.
ROHWER, A., BOOTH, A., PFADENHAUER, L., BRERETON, L., GERHARDUS, A., MOZYGEMBA, K., OORTWIJN, W., TUMMERS, 
M., VAN DER WILT, G.J., REHFUESS, E. (2016) Guidance on the Use of Logic Models in Health Technology 
Assessments of Complex Interventions [Online]. Available from: http://www.integrate-hta.eu/down-
loads/ 
ROSAS, M.A., BEZERRA, A.F., DUARTE-NETO, P.J. (2013) Use of artificial neural networks in applying methodology 
for allocating health resources. Rev Saude Publica, 47, 128-136.
ROTHMAN, D. (1941) Monte Carlo techniques: an overview.
ROY, B. (1968) Classement et choix en présence de points de vue multiples. Revue française d‘automatique, 
d‘informatique et de recherche opérationnelle. Recherche opérationnelle, 2, 57-75.
RYCROFT-MALONE, J., MCCORMACK, B., HUTCHINSON, A.M., DECORBY, K., BUCKNALL, T.K., KENT, B., SCHULTZ, A., SNEL-
GROVE-CLARKE, E., STETLER, C.B., TITLER, M., WALLIN, L., WILSON, V. (2012) Realist synthesis: illustrating 
the method for implementation research. Implement Sci, 7, 33.
SAATY, T.L. (1977) A scaling method for priorities in hierarchical structures. Journal of Mathematical Psychology, 
15, 234-281.
SAATY, T.L. (1996) The analytic network process: decision making with dependence and feedback; the organiza-
tion and prioritization of complexity. New York: Rws Publications.
SAATY, T.L. (2001) Analytic network process. In: GASS, S.I., HARRIS, C.M. (eds.). Encyclopedia of Operations Rese-
arch and Management Science (2 ed). New York: Springer US.
SAATY, T.L. (2004) Fundamentals of the analytic network process — Dependence and feedback in decision-making 
with a single network. Journal of Systems Science and Systems Engineering, 13, 129-157.
SANTOS, F.A., MARGOTTI, A.E., GARCIA, R. (2013) Multi-Criteria Decision Aid (MCDA) as a Tool to Support Health 
Technology Incorporation Process. In: LONG, M. (ed.). World Congress on Medical Physics and Biome-
dical Engineering May 26-31, 2012, Beijing, China. Berlin Heidelberg: Springer 
SEGHIERI, C., MENGONI, A., NUTI, S. (2014) Applying Discrete Choice Modelling in a Priority Setting: An Investigati-
on of Public Preferences for Primary Care Models. European Journal of Health Economics, 15, 773-785.
SHEPARD, R.N. (1964) On subjectively optimum selection among multiattribute alternatives. Human judgments 
and optimality, 257-281.
SHIELL, A., HAWE, P., GOLD, L. (2008) Complex interventions or complex systems? Implications for health economic 
evaluation. BMJ, 336, 1281-1283.
SIEBERT, U. (2003) When should decision-analytic modeling be used in the economic evaluation of health care? 
The European Journal of Health Economics, formerly: HEPAC, 4, 143-150.
STAHL, J.E. (2008) Modelling Methods for Pharmacoeconomics and Health Technology Assessment. PharmacoEco-
nomics, 26, 131-148.
STEVENSON, A. (2005) Oxford Dictionary of English. (2 ed).Oxford: Oxford University Press.
STEWART, G.B., MENGERSEN, K., MEADER, N. (2014) Potential uses of Bayesian networks as tools for synthesis of 
systematic reviews of complex interventions. Research Synthesis Methods, 5, 1-12.
THE JOANNA BRIGGS INSTITUTE (2014) Joanna Briggs Institute Reviewers’ Manual 2014 Edition. Australia: Joanna 
Briggs Institute.
45 |
TONY, M., WAGNER, M., KHOURY, H., RINDRESS, D., PAPASTAVROS, T., OH, P., GOETGHEBEUR, M.M. (2011) Bridging 
health technology assessment (HTA) with multicriteria decision analyses (MCDA): Field testing of the 
EVIDEM framework for coverage decisions by a public payer in Canada. BMC Health Serv Res, 11, 1-13.
TREWEEK, S., OXMAN, A.D., ALDERSON, P., BOSSUYT, P.M.M., BRANDT, L., BROŽEK, J., DAVOLI, M., FLOTTORP, S., HAR-
BOUR, R., HILL, S., LIBERATI, A., LIIRA, H., SCHÜNEMANN, H.J., ROSENBAUM, S., THORNTON, J., VANDVIK, 
P.O., ALONSO-COELLO, P. (2013) Developing and evaluating communication strategies to support infor-
med decisions and practice based on evidence (DECIDE): protocol and preliminary results. Implemen-
tation Science, 8, 1-12.
VAN HOORN, R., TUMMERS, M., KIEVIT, W., VAN DER WILT, G.J. (2016) Guidance for the assessment of treatment mo-
deration and patients' preferences [Online]. Available from: http://www.integrate-hta.eu/downloads/ 
VON WINTERFELDT, D., FISCHER, G.W. (1975) Multiattribute utility theory: Models and assessment procedures. 
Utility, probability, and human decision making, 11, 47-86.
WAHLSTER, P., GOETGHEBEUR, M., KRIZA, C., NIEDERLANDER, C., KOLOMINSKY-RABAS, P., NATIONAL LEADING-EDGE 
CLUSTER MEDICAL TECHNOLOGIES ‚MEDICAL VALLEY EMN‘ (2015a) Balancing costs and benefits at different 
stages of medical innovation: a systematic review of Multi-criteria decision analysis (MCDA). BMC He-
alth Serv Res, 15, 262.
WAHLSTER, P., GOETGHEBEUR, M., SCHALLER, S., KRIZA, C., KOLOMINSKY-RABAS, P. (2015b) Exploring the perspectives 
and preferences for HTA across German healthcare stakeholders using a multi-criteria assessment of a 
pulmonary heart sensor as a case study. Health Research Policy and Systems, 13, 24.
WHITTY, J.A., BURTON, P., KENDALL, E., RATCLIFFE, J., WILSON, A., LITTLEJOHNS, P., SCUFFHAM, P.A. (2014a) Harnes-
sing the potential to quantify public preferences for healthcare priorities through citizens‘ juries. Int 
J Health Policy Manag, 3, 57-62.
WHITTY, J.A., RATCLIFFE, J., CHEN, G., SCUFFHAM, P.A. (2014b) Australian public preferences for the funding of new 
health technologies: A comparison of discrete choice and profile case best-worst scaling methods. 
Medical Decision Making, 34, 638-654.
WHOLEY, J.S. (1987) Evaluability assessment: Developing program theory. New Directions for Program Evaluation, 
1987, 77-92.
WINTERFELDT, D., EDWARDS, W. (1993) Decision analysis and behavioral research. New York: Cambridge University 
Press.
WOERTMAN, W., SLUITER, R., VAN DER WILT, G.J. (2014) Synthesis of Evidence for Reimbursement Decisions: A Bay-
esian Reanalysis. Int J Technol Assess Health Care, 30, 1-8.
YNTEMA, D.B., TORGERSON, W.S. (1961) Man-Computer Cooperation in Decisions Requiring Common Sense. Human 
Factors in Electronics, IRE Transactions on, HFE-2, 20-26.
YOO, H.I., DOIRON, D. (2013) The Use of Alternative Preference Elicitation Methods in Complex Discrete Choice 
Experiments. Journal of Health Economics, 32, 1166-1179.
ZADEH, L.A. (1965) Fuzzy sets. Information and Control, 8, 338-353.
| 46 
7 ACKNOWLEDGEMENT
We are grateful for the valuable support we recei-
ved from external experts, stakeholders parti-
cipating in the case study, members of the INTE-
GRATE-HTA project and all other supporters not 
explicitly mentioned here during the development 
of the presented guidance. We especially thank the 
European Union for funding this project. 
8  APPENDIX
8.1 MAPPING REVIEW ON  
INTEGRATION
A mapping review was conducted to identify inte-
gration methods to integrate the different dimen-
sions of information in HTA.  As in all systematic 
reviews, the search strategy is systematic to fully 
cover the field of literature. In contrast to syste-
matic reviews, mapping reviews however do not 
require a formal quality assessment for included 
studies or a specific tool for the synthesis and ana-
lysis of the results. 
8.1.1 Methods of the mapping review
Information sources and search
We searched the Web of Science; Medline, PsycINFO 
and the non-medical databases Econlit, ASSIA, In-
ternational Bibliography of the Social Sciences and 
Sociological abstracts for the period January 2004 
to April 2014. Keywords used were “Decision Sup-
port Techniques/ or *Decision Making”; “evidence* 
or perspective*”; “multi or context”; “criteria or 
element* or component* or attribute*”; “ethics or 
bioethics or equity or justice”; “societal or cultu-
ral” “concern* or norm*”; “preference* or point of 
view”; “integrat*”; “issue* or priorit* or aspect* 
or* process* or concept* or tool* or technique* or 
approach* or framework* or consider*”; “Resource 
Allocation/ or *Health Priorities/ or *Health Rati-
oning”; “priorit* or decision* or coverage or po-
licy or ration* or resource* or choice* or deliberat* 
or iterat* or panel or assumption*”.The keywords 
were adapted to each database. Additional articles 
were found in the references and citations of the 
retrieved articles.
Study selection 
The title and abstracts of all retrieved articles were 
reviewed in the first instance by PW. Where the 
decision about inclusion was unclear, a second re-
searcher (AG) was involved. Inclusion criteria used 
are listed in table 5. 
Methods were appraised with respect to their ap-
plicability to HTA. The categories of the data ext-
raction form address the four dimensions in HTA 
that need integration (chapter 2.2). 
Data collection process and data items
The date extraction table 8 guides the selection 
of methods as well as the mapping of the inclu-
ded methods. The template for data extraction was 
pre-tested using a sample of studies before full 
data extraction was initiated. Several publications 
could be used for referencing a particular method 
in the data extraction. Additional papers were re-
trieved if the description of a particular method 
was not sufficient. 
Reporting of Results – integration methods
After completing the data extraction, a narrative 
synthesis was compiled according to the objective 
to present a comprehensive and practical overview 
of how to cover different dimensions of integration 
in HTA. Methods were described to obtain a general 
overview. By doing this, a map of integration me-
thods was obtained.
Synthesis of results –fields of application for in-
tegration
Afterwards, the methods were systematically di-
saggregated to identify areas of application for in-
tegration (Table 9). The identified areas of applica-
tion in HTA highlight similar means of integration 
in different methods. These areas of application 
provide guidance on suitable combinations of dif-
ferent methods. 
 
8.1.2 Results of the mapping review: 
integration methods
The 30 methods identified from the mapping re-
view include 7 (23%) qualitative, 14 (46%) quan-
titative and 9 (31%) mixed methods. We categori-
zed the methods into four main categories: MCDA 
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methods, analytic methods, preference elicitation 
methods, and consensus methods. 
A description of all methods is provided in table 
6 below.
8.1.3 Areas of application - extracted 
from the methods identified
The areas of application describe common patterns 
of integration in different methods and provide 
guidance on suitable combinations of different me-
thods. The 9 areas of application are partially over-
lapping e.g. the techniques 1, 2, 3 and 6 are over-
lapping regarding the structure of decision criteria 
(Table 7 below).
 
Technique 1: Structuring of an HTA question into 
assessment criteria: 
The separation of an HTA objective into clearly de-
fined assessment criteria provides a basis for in-
tegration at the end of the assessment that was 
derived from MCDA methods. A clear definition and 
structure of the assessment criteria is important to 
assign assessment results (dimension 1) to certain 
criteria, such as “Meaningfulness” as one assess-
ment criterion for the HTA case study on palliati-
ve care that was addressed by several assessment 
aspects e.g. patient characteristics, socio-cultural, 
legal aspects. 
The assessment criteria of the HTA research question 
can either be presented alongside each other, struc-
tured in a hierarchy or a network (e.g. effectiveness 
in palliative care can be hierarchically structured 
into effectiveness for patients and effectiveness for 
caregiver with different outcome parameters for 
both groups). Alternatively, the ANP (Analytic Net-
work process) describes a quantitative approach 
which structures criteria into a network to illustrate 
the interdependencies between them (Saaty, 2004). 
In this way, potential overlaps between different 
Table 5: Inclusion criteria.
No Category Criteria
1 Year of release January 2004- April 2014
2 Assessment topic Medical and non-medical decision problems
3 Framework Methods (concepts / approaches/ frameworks / models) including multiple, 
quantitative or qualitative aspects
4 Dimensions in HTA Address dimensions in HTA (categories of the data extraction framework 
about integration)
5 Integration Approaches that describe how (the process) these relevant issues should be 
considered: Should include connective elements to merge/ aggregate/ ad-
dress interdependencies between aspects
6 Type of article Articles that describe/apply a certain method
7 Source of publication Peer reviewed journals and websites of health care authorities
8 Language English, German
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Table 6: Description of all methods identified in the systematic review.
MCDA methods
ﬁ  Value based methods calculate a value estimate for each decision option. Low perfor-
mance on one criterion can be outweighed by higher performance in another criterion. 
AHP (Analytic hierarchy process) (Hummel et al., 2012; Liberatore & Nydick, 2008; Saaty, 1977) starts by di-
viding the decision problem into different assessment criteria. These criteria are arranged into a hierarchy 
with main criteria and sub criteria. Following this arrangement, participants can perform trade-offs between 
the criteria by using a pairwise comparison between criteria on a 17-point-scale. Afterwards the trade-offs 
are entered into matrices and calculated by the eigenvector approach. The outputs of these calculations are 
value estimates for each decision option. These calculations include the calculation of an inconsistency score 
to trigger consensus among participants. When significant inconsistencies are observed, decision-makers can 
review their ratings. One theoretical problem regarding AHP which needs mentioning is the rank reversal is-
sue. This means that the extension of the list of decision options by one additional option can cause a rever-
sal of the ranking of two other options that are not related to the new additional decision option in any way. 
ANP (Analytic Network process) (Saaty, 2001; Saaty, 1996) is similar to AHP. The major difference is that in ANP 
the criteria are structured as a network, and not as a hierarchy. Consequently, the weighting and scoring 
procedure becomes more complex, resulting in a supermatrix to additionally assess the interdependencies of 
criteria. The major advantage of ANP is that the network structure quantifies the interdependencies between 
different criteria. 
REMBRANDT (Ratio Estimation in Magnitudes or deci-Bells to Rate Alternatives which are Non-DominaTed) 
(Lootsma, 1992) was developed to overcome some of AHP’s theoretical problems, such as the rank reversal 
issue. The method provides a direct rating system on a logarithmic scale from +8 to -8, depending on which 
of the two criteria being compared is preferred over the other. The advantage of this logarithmic scale is 
that the calculations of the value estimate are simplified. Whereas AHP needs to calculate the eigenvector, 
REMBRANDT uses the geometric means from the pairwise comparison matrices for the final ranking of the 
decision options.
MACBETH (Measuring Attractiveness by a Category Based Evaluation Technique) (Bana E Costa & Vansnick, 1999) 
is another variation of the AHP. Following the basic principles of AHP, participants perform pairwise compa-
risons between 2 criteria on a simplified scale from 1 to 6, with 1 indicating a very weak difference between 
two criteria, and 6 an extreme difference. 
EVIDEM (Evidence based decision-making) (Goetghebeur et al., 2012; Goetghebeur et al., 2008; Goetghebeur 
et al., 2010; Miot et al., 2012; Tony et al., 2011) consists of 15 core criteria that are specific for HTA decisi-
on-making, such as severity of disease. EVIDEM provides several weight elicitation methods. The most popular 
technique is the direct weighting approach, which is mostly used with a scale from 1 to 5. Firstly, the 15 core 
criteria are weighted independent of the assessed technology. Secondly, the performance of the technology 
is scored against each core criterion. Thirdly, a value estimate is calculated by combining weights and scores. 
Other options are point allocation, ranking in a hierarchical structure, pairwise comparison in a hierarchical 
structure, similar to the AHP rating, or best-worst scaling. 
Swing weighting method (Belton & Stewart, 2002) and SMARTS (Simple Multi-Attribute Rating Technique Using 
Swings) (Edwards & Barron, 1994b; Edwards & Barron, 1994a; Winterfeldt & Edwards, 1993) are an advan-
cement of the direct weighting approach using swing weights. Whereas weights in direct weighting reflect 
only the importance of a criterion, swing weights reflect both the importance of a criterion as well as the 
importance of the effect size. 
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Program budgeting and marginal analysis (PBMA) (Goodwin & Frew, 2013; Mitton & Donaldson, 2001; Mitton 
et al., 2003) explicitly considers the available budget and the budget impact of the decision options. Hence, 
the decision options are put into three categories: a) Funding growth areas with new resources, b) Decisions 
to move resources to areas with service growth, and c) Trade-off decisions to move resources. A deliberative 
discussion of decision-makers is based on these categories.
MAUT (Multi-attribute utility theory) (Shepard, 1964; Von Winterfeldt & Fischer, 1975; Yntema & Torgerson, 
1961) translates the performance of options into utilities in different scenarios. Decision-makers estimate 
the probability of each scenario. The value of a specific option is calculated as the subjective expected utility 
(SEU), the sum of the utilities in all scenarios multiplied by the probability of each scenario. Afterwards, all 
options are compared regarding their SEU.
ﬁ  Outranking methods do allow incomparability between the performances of different decision options. 
As such, low performance on one criterion cannot be outweighed by higher performance in another criterion.
ELECTRE (ELimination and Choice Expressing REality) (Crama & Hansen, 1983; Roy, 1968) aims to identify do-
minance relations between different options. For each criterion the dominant option will receive predefined 
weights, which represent the relative importance of the criterion. The option that outranks all other options 
should be selected. 
PROMETHEE (Preference Ranking Organisation Method for Enrichment Evaluation) (Brans et al., 1986) is a 
method used to define preference functions. These preference functions describe a criterion’s threshold of 
importance (e.g. 1 week of survival gain) as well as its gradient (e.g. the importance doubles if the survival 
gain is 4 weeks). Thereafter, outranking relationships between different options are calculated. 
ﬁ  Reference based methods compare the decision options with respect to an ideal alternative. 
In goal programming (Charnes & Cooper, 1957; Charnes et al., 1955) the ideal performance on each decision 
criterion is defined as a goal. The differences between the goals desired and the performance of the real 
decision options are compared on all decision criteria. Accordingly, the best decision option is closest to the 
goal desired across all criteria.
TOPSIS (Technique for Order Preference by Similarity to Ideal Solution) describes a similar method to goal pro-
gramming (Hwang & Yoon, 1981). For each criterion, the alternatives are compared regarding the distance 
from the Positive Ideal Solution (PIS) and the Negative Ideal Solution (NIS). The closeness coefficients that 
summarise the distance from PIS and NIS of each alternative are used to rank the alternatives.
ﬁ  Non compensatory MCDA methods (Dodgson et al., 2009; Guitouni & Martel, 1998) differ from other 
MCDA methods as they do not allow trade-offs between different criteria. These methods use thresholds for 
different criteria, or apply lexicographical rankings to opt alternatives out.  
Analytic approaches
ﬁ  Modeling methods provide insights into the magnitude of an effect for new health tech-
nologies.
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Modeling methods such as decision trees and simulation approaches (Rothman, 1941; Siebert, 2003; Stahl, 
2008) can calculate quantitative outcomes such as costs and medical outcomes of health interventions. These 
methods require clear definitions of the health care pathway related to the technology of interest and data 
input to model the outcome at the end of the health care pathway. 
The efficiency frontier concept (Caro et al., 2010; Koch, 2010) aims to integrate costs and effects of multiple 
interventions for specific outcome parameters. These parameters are plotted against the intervention costs 
in comparison to already existing interventions. The efficiency frontier thereby illustrates the gradient of 
improvement in outcomes versus the increase in costs.
Artificial neural networks (Basheer & Hajmeer, 2000; Rosas et al., 2013) are learning modeling systems and 
can be applied in a broad range of real-world problems. They can detect connections and patterns in data 
and adapt themselves accordingly. 
ﬁ  Probability-based methods provide insights into the likelihood of an effect for new he-
alth technologies.
Bayesian networks (Bayes & Prices, 1763; Pearl, 1985) describe a network consisting of nodes representing 
health care parameters. These nodes are interlinked by probability functions. Thresholds for specific outcome 
parameters define clinical relevance. The structure and the parameters of a Bayesian network (BNs) can be 
obtained from experts. 
The Dempster–Shafer theory (DST) (Beynon et al., 2000; Dempster, 1967) is similar to the Bayesian approach. 
The evidence is decomposed into different statements and their plausibility in comparison to other statem-
ents. The outputs are statements with specific likelihoods.
Value of Information (VOI) analysis (Claxton et al., 2001; Howard, 1966) can clarify whether new data should be 
gathered. The expected value of perfect information (EVPI) is the willingness of decision-makers to pay for the un-
certainty in the decision to be addressed. The expected value of partial perfect information (EVPPI) is the value dif-
ference between a decision based on perfect information on a subset of parameters and the current information. 
Fuzzy logic (Grabisch, 1995; Murofushi & Sugeno, 1989; Murofushi & Sugeno, 1991; Zadeh, 1965) provides 
an intuitive way of scaling outcome parameters. Overlapping ranges describe the fuzziness of parameters. 
Experts can determine the fuzzy sets for parameters.
ﬁ  Qualitative modelling methods illustrate the relation between all outcomes which con-
tain qualitative and quantitative elements.
Logic models (Conrad et al., 1999; Wholey, 1987) allow the identification of patients, interventions, com-
parators, outcomes, context and implementation, thus providing a comprehensive and generic structure for 
the decision problem.
Reasoning mapping (Axelrod, 2015; Montibeller et al., 2008) is based on the decision-makers’ reasoning of 
a decision problem. The decision problem is divided into different attributes. The context between attributes 
is illustrated as links of different strength (positive or negative) between attributes. 
Preference elicitation approaches
DCEs (Discrete Choice experiments) (McFadden, 1976; McFadden, 1975) separate the decision criteria into dif-
ferent levels. Participants are asked to decide between two scenarios consisting of variations in criteria and 
levels. These ratings form the base for the calculation of preferences for every criterion and level.
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Best-worst rating (BWS) (Finn & Louviere, 1992; Flynn et al., 2007; Potoglou et al., 2011; Yoo & Doiron, 2013) 
provide an alternative rating system. Participants have to rate the best and the worst criterion of each scena-
rio. These ratings form the base for the calculation of preferences for every criterion and level. 
Consensus methods
ﬁ  General consensus methods are used for discussions of the final information (in this case 
the assessment results of the HTA) that informs the decision.
Consensus Reaching Processes (CRPs) (DeGroot, 1974; Eisenberg & Gale, 1959; Palomares et al., 2014) descri-
be a variety of methods to measure the distances between different expert opinions or between individual 
and collective opinions. A feedback mechanism is intended to decrease these differences (numerical, inter-
vals or linguistic). 
The Delphi method (Dalkey & Helmer-Hirschberg, 1962) guides the decision panel on how to structure and 
to rate the decision problem according to e.g. alternatives, criteria, values and outcomes. Thereafter, the 
participants rate these aspects. These ratings form the basis for the discussion in the next Delphi round. This 
process should be repeated until consensus is reached.
Nominal group technique (NGT) (Allen et al., 2004; Delbecq & Van de Ven, 1971) is designed to include all 
participants in decision-making. Participants write down their individual viewpoints regarding a decisi-
on-problem. These viewpoints then form the basis for a discussion among the group. Through this discussion, 
different aspects of the decision problem can be finally ranked by the group.
A Citizens’ jury (Crosby et al., 1986; Whitty et al., 2014a) comprises a random sample of the public who are 
involved in the decision-making. The citizens’ jury provides a public viewpoint and ensures that the prefe-
rences and values of the public are included in the decision-making process.
ﬁ  Process-based consensus methods are used for discussions during the assessment pro-
cess that results in the final information for decision-making.
GRADE (Grading of Recommendations, Assessment, Development and Evaluation)/ Developing and Evaluating 
Communication Strategies to Support Informed Decisions and Practice Based on Evidence (DECIDE) (Atkins et 
al., 2004; Gopalakrishna et al., 2014; Guldbrandsson et al., 2015; Guyatt et al., 2008; Hsu et al., 2011; 
Treweek et al., 2013) aims at assessing the quality of evidence, the balance of desirable and undesirable 
consequences, values and preferences, and the use of resources. GRADE integrates the ratings on the quality 
of evidence (on a scale of 1 to 4) with ratings on the importance of certain outcomes (on a scale from 1 to 
9) in a deliberative process. As GRADE does not inform users about how to take qualitative evidence such as 
context and implementation issues into account, it was developed further resulting in the tool DECIDE. DECIDE 
extends the list of criteria that are provided by GRADE and provides computer-based tools to comprehensively 
illustrate different criteria and the underlying evidence. 
Realist synthesis (Pawson et al., 2004; Rycroft-Malone et al., 2012) describes an iterative process for syste-
matic reviews. By doing this, the assessment methods can be adapted with respect to the specific decision 
context (such as the assessment of RCT or observational studies. The results should not only answer the ques-
tion whether the intervention is working, but also why the intervention is working, and in which context. 
Finally, stakeholders can review the findings to provide useful recommendations. 
| 52 
assessment aspects (dimension 1) can be identi-
fied and addressed from before the application of 
the different assessment methods (such as overlaps 
between the assessment of context, implementati-
on and the ethical and socio-cultural aspects). The 
selection process for the assessment criteria as well 
as the process of structuring the criteria should be 
guided by the objectives and values of decision ma-
kers (dimension 4). Thus, the dimensions 1 and the 
dimension 4 are integrated from the very beginning 
of HTA.
Technique 2: Performance matrix of the assessment 
results: 
A performance matrix entails the graphical illustra-
tion of the assessment results (dimension 1) which 
is useful for structured qualitative decision-making, 
taking values and preferences of stakeholders (di-
mension 4) into account. Afterwards, this eviden-
ce is deliberated on in conjunction with additional 
criteria that are put forward by committee mem-
bers (Coast, 2004). Based on a performance mat-
rix, non-compensatory MCDA methods quantitatively 
compare different options by using different con-
cepts: dominance; lexicographic ordering, or pre-
selection via thresholds of certain criteria (or all 
criteria) (Dodgson et al., 2009). For instance, the 
performance matrix can lead to clear decisions if a 
particular technology dominates the performance in 
all assessment criteria.
Technique 3: Qualitative modelling techniques to il-
lustrate all relevant assessment aspects:
Qualitative modelling techniques such as logic mo-
dels represent a graphical illustration of context, 
implementation and interdependencies between 
different compounds of a technology. Logic models 
can be used to link and integrate different aspects 
of complex technologies (Anderson, 2011; Baxter et 
al., 2010). Reasoning mapping illustrates the cont-
Table 7: Relation between areas of application and approaches.
Area of application Overlaps with 
other area of 
application
Number of approa-
ches assigned to the 
area of application
1   Structuring of the HTA into assessment criteria 16
2   Performance matrix of the assessment results 1 14
3   Qualitative modelling techniques to illustrate all 
relevant assessment aspects
2
4   Process based integration 2
5   Scoring and calculation techniques to integrate  
assessment criteria
1, 2 14
6   Providing structured input for deliberative  
discussions
2, 5 3
7   Structuring a deliberative discussion 5 4
8   Integrating uncertainty by using assessment criteria 5 6
9   Integrating uncertainty of evidence 6
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ext between different decision attributes, using ar-
rows of different strength (positive or negative) bet-
ween the respective attributes (Montibeller et al., 
2008). The application of this modelling technique 
can illustrate the relation between all assessment 
aspects (dimension 1) and the modifying factors (di-
mension 2) in a comprehensive manner. For instan-
ce, specific patient characteristics (such as religious 
affiliation) can influence the outcome of palliative 
care with a specific compound of spiritual care. This 
way of presentation can increase the understanding 
of the interactions between the health care system 
and health technologies for HTA.
Technique 4: Process based integration to address 
interactions within the assessment:
This technique links the inputs (the evidence/out-
come parameters to be assessed) and outputs (the 
assessment results) regarding the different interac-
ting assessment aspects. The output of one assess-
ment aspect can be the input for the assessment 
of another aspect. For instance, assessment results 
on modifying factors (dimension 2) such as patient 
preferences for death at home can feed as an outco-
me parameter into the assessment of effectiveness 
(dimension 1) to assess if reinforced palliative care 
helps patients die at home. Stakeholders can be in-
volved and contribute their perspectives (dimensi-
on 4) throughout different steps of the assessment 
process. The GRADE methodology also covers some 
aspects of process-based integration: GRADE guides 
a process from the evidence synthesis to the deci-
sion-making process. A panel formulates the rese-
arch question according to the PICO (Participants, 
Intervention, Comparator, Outcomes) scheme and 
rates the importance of certain outcomes. Finally, 
the results of the evidence synthesis are discussed 
according to pre-defined criteria.
Technique 5: Scoring and calculation approaches to 
integrate assessment criteria:
These techniques are classified under MCDA approa-
ches to systematically integrate the assessment re-
sults (dimension 1, 2 and 3) and values of preferen-
ces of stakeholders (dimension 4). For instance, the 
application of MCDA in the case study on palliative 
care could quantitatively indicate that the eviden-
ce on effectiveness for caregivers contributed with 
59% to the overall value of reinforced models of 
care for participating stakeholders. As outlined in 
the description of MCDA approaches in the appen-
dix, there are various MCDA methods available.
Technique 6: Providing structured input for delibe-
rative discussions: 
There is a large variety of structured inputs available 
for a deliberative discussion between stakeholders 
and decision makers (dimension 4). For instance, 
EVIDEM developed a contextual tool for non-quanti-
fiable criteria. Using the tool, all qualitative criteria 
are assessed whether they have a positive, negative 
or neutral influence on the decision. The final dis-
cussion is then based on this rating. The final dis-
cussion using GRADE is structured according to four 
criteria: quality of evidence, balance benefits/harm; 
the value and preference and resource use (costs).
Technique 7: Structuring a deliberative discussion:
Several approaches to structure a deliberative di-
scussion were identified to reinforce the input of 
all participating stakeholders (dimension 4). For in-
stance, by applying Nominal group technique (NGT), 
participants write down their individual viewpoints 
regarding a decision problem. These viewpoints 
then form the basis for the discussion among the 
group. Through this discussion, different aspects of 
the decision problem can be finally ranked by the 
group.
Technique 8: Integrating uncertainty by using as-
sessment criteria:
Uncertainty of evidence can be addressed by using 
specific assessment criteria for uncertainty. For in-
stance, GRADE and EVIDEM consider the validity and 
consistency of evidence as separate assessment cri-
teria. Preferences of stakeholders can indicate the 
importance of these criteria according to technique 
6. Uncertainty can also be considered in the scaling 
system of other assessment criteria (e.g. by provi-
ding ranges of scores for assessment criteria). For 
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instance, the evidence can indicate a pivotal effect 
regarding quality of life for reinforced models of 
palliative care. As the uncertainty around the study 
quality was high, stakeholders could rate the effect 
including the uncertainty surrounding this effect 
with a range from +2 to +5 on a scale from 0 (no 
effect) to 5 (substantial effect). In this way, uncer-
tainty (dimension 3) and the preferences and per-
spectives of decision makers (dimension 4) can be 
brought together.
Technique 9: Integrating uncertainty of evidence: 
Evidence on different assessment aspects (e.g. the 
outcome of reinforced palliative home care on pa-
tients’ quality of life and the assessment results on 
patient moderators regarding quality of life) can be 
processed to obtain integrated information about 
the probability for an effect regarding quality of life 
for specific patients. Consequently, this technique 
provides integrated information on assessment re-
sults (dimension 1), modifying factors (dimension 2) 
and uncertainty surrounding the results (dimension 
3). Analytic methods such as decision trees (Cooper 
et al., 2005) or simulation approaches (Arunraj et 
al., 2013) provide these outputs. Bayesian networks 
are especially useful for illustrating uncertain-
ty in complex systems. The Bayesian networks can 
be constantly updated when new evidence comes 
in (Stewart et al., 2014; Woertman et al., 2014), 
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